<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/</loc>
		<lastmod>2026-10-22T12:55:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/56488flamel_moves_hepatitis_product_into_phase_i/</loc>
		<lastmod>2004-12-21T04:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/554b7dynavax_allergy_product_shows_promise_in_/</loc>
		<lastmod>2004-12-21T04:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/424a7neurogen_starts_phase_i_trial_for_lead_insomnia_cand/</loc>
		<lastmod>2004-12-21T04:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/13490methylgene_initiates_first_phase_i_blood_cancers_tr/</loc>
		<lastmod>2004-12-21T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a48agenaissance_research_could_predict_drug_side_effect/</loc>
		<lastmod>2004-12-21T12:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/61496cambridge_antibody_technology_soars_on_abbott_trial_vi/</loc>
		<lastmod>2004-12-21T13:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf499epivax_wins_second_biodefense_award_for_small/</loc>
		<lastmod>2004-12-21T13:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e48abms_and_gilead_establish_landmark_hiv_ve/</loc>
		<lastmod>2004-12-21T13:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/03493new_formulation_of_roche_hiv_drug_fdaappro/</loc>
		<lastmod>2004-12-21T13:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e4bfcardiomes_pivotal_cardio_study_achieves_primary_endpo/</loc>
		<lastmod>2004-12-21T13:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154b1threshold_initiates_phase_iii_pancreatic_cancer_/</loc>
		<lastmod>2004-12-21T13:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c448ecentocor_and_scheringploughs_remicade_approved_in_spine_disor/</loc>
		<lastmod>2004-12-21T13:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8548aencysive_blood_pressure_drug_less_promising_than_exp/</loc>
		<lastmod>2004-12-21T13:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f5484genmab_and_medarex_autoimmune_treatment_safe_and_efficient_in_phase/</loc>
		<lastmod>2004-12-22T13:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/084b4ym_biosciences_cancer_therapy_achieves_positive_phase_ii_re/</loc>
		<lastmod>2004-12-22T13:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/17492chondrogene_and_pfizer_sign_new_osteoarthritis_p/</loc>
		<lastmod>2004-12-22T13:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf49cantisense_thera_and_isis_move_multiple_sclerosis_drug_into_patient_tri/</loc>
		<lastmod>2004-12-22T13:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e4a2immunicon_and_pfizer_extend_tumor_rd_agre/</loc>
		<lastmod>2004-12-22T13:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/724a3cell_therapeutics_and_quintiles_enter_anticancer_financing_agre/</loc>
		<lastmod>2004-12-22T13:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b1494genzyme_boosts_its_cancer_presence_with_ilex_acquisit/</loc>
		<lastmod>2004-12-22T13:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/68492nabi_seeks_eu_approval_of_staphvax_in_kidney_dise/</loc>
		<lastmod>2004-12-22T13:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f048efurther_confusion_as_pfizers_celebrex_shows_cardio_safety_in_alzheime/</loc>
		<lastmod>2004-12-22T13:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8249bavi_signs_dengue_biodefense_agre/</loc>
		<lastmod>2004-12-22T13:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/024bbarena_pharmaceuticals_and_orthomcneil_ink_diabetes/</loc>
		<lastmod>2004-12-22T13:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c2496biogenelan_drug_to_be_pitted_against_seronopfizer_rival_in/</loc>
		<lastmod>2004-12-22T13:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/254b3ucb_pharma_files_two_applications_for_epilepsy_drug/</loc>
		<lastmod>2004-12-23T08:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f24a6abbott_seeks_further_approvals_for_arthritis_drug_h/</loc>
		<lastmod>2004-12-23T08:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d64a6therion_cancer_vaccine_shows_antitumor_activ/</loc>
		<lastmod>2004-12-23T08:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b3481tapestry_files_to_test_novel_anticancer_drug_in_h/</loc>
		<lastmod>2004-12-23T08:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/274a3access_seeks_clearance_for_phase_i_solid_tumors_tr/</loc>
		<lastmod>2004-12-23T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/744bbppd_and_syrrx_file_to_advance_diabetes_drug_into_phase_/</loc>
		<lastmod>2004-12-23T08:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4b2bms_and_angiotech_cancer_drugs_may_benefit_alzheimers_and_parkin/</loc>
		<lastmod>2004-12-23T08:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/614a5bms_and_somerset_pen_antidepressant/</loc>
		<lastmod>2004-12-23T09:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/67490mannkind_reports_positive_phase_ii_diabetes/</loc>
		<lastmod>2004-12-23T09:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f0488oxigene_begins_phase_i_novel_anticancer_tr/</loc>
		<lastmod>2004-12-23T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f4aebiovail_begins_legal_action_over_antidepressant_generic/</loc>
		<lastmod>2004-12-23T09:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984b3arena_pharmaceuticals_lead_obesity_compound_enters_pha/</loc>
		<lastmod>2004-12-23T09:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/684a0pfizer_nerve_drug_may_see_setba/</loc>
		<lastmod>2005-01-04T12:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4482neuro3d_completes_429_million_fund/</loc>
		<lastmod>2005-01-04T12:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104besupergen_shares_retreat_on_cancer_drug_withdra/</loc>
		<lastmod>2005-01-04T12:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4b1mgi_and_supergens_dacogen_accepted_for_r/</loc>
		<lastmod>2005-01-04T12:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1549dhemispherx_begins_hiv_clinical_pr/</loc>
		<lastmod>2005-01-04T12:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54a8sinovac_profits_surge_230_private_financing_com/</loc>
		<lastmod>2005-01-04T12:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e8488atherogenics_suffers_on_cardio_trial_d/</loc>
		<lastmod>2005-01-04T12:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b648fbasilea_antifungal_enters_pha/</loc>
		<lastmod>2005-01-04T12:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a4b2glaxo_lymphoma_regimen_gets_expanded_app/</loc>
		<lastmod>2005-01-04T12:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac485teva_parkinsons_treatment_cleared_for_first_lau/</loc>
		<lastmod>2005-01-04T12:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b84bdadolor_and_gsk_to_copromote_thrombosis_treatm/</loc>
		<lastmod>2005-01-04T12:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4480shire_signs_nonbinding_deal_for_adhd_compo/</loc>
		<lastmod>2005-01-04T12:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b49dlilly_and_novartis_schizophrenia_drugs_may_increase_diabetes_r/</loc>
		<lastmod>2005-01-04T12:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b748ccell_thera_licenses_diabetes_candidate_to_di/</loc>
		<lastmod>2005-01-04T12:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c485bms_signs_antibiotics_sales_deal_with_ventiv_pha/</loc>
		<lastmod>2005-01-04T12:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a4a3alnylam_begins_respiratory_illness_program/</loc>
		<lastmod>2005-01-05T09:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94a1dimethaid_up_on_solvay_arthritis_dea/</loc>
		<lastmod>2005-01-05T09:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/564adprana_gets_uk_ok_for_milestone_alzheimers_/</loc>
		<lastmod>2005-01-05T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d49avitae_gets_new_life_with_fu/</loc>
		<lastmod>2005-01-05T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/804bftargeted_genetics_and_celladon_to_develop_cardio_ther/</loc>
		<lastmod>2005-01-05T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0849eneopharm_and_nippon_kayaku_sign_brain_tumor_agreem/</loc>
		<lastmod>2005-01-05T10:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e484bms_and_otsuka_get_approval_for_new_abilify_formulat/</loc>
		<lastmod>2005-01-05T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b485astrazeneca_pulls_european_iressa_applic/</loc>
		<lastmod>2005-01-05T10:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/36499andrx_abandons_brands_in_favor_of_generics_ends_pfizer_dea/</loc>
		<lastmod>2005-01-05T11:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf4a4targegen_begins_phase_iii_trial_in_heart_attack_patients/</loc>
		<lastmod>2005-01-05T11:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/19485h3_pharma_gets_approvable_letter_for_san/</loc>
		<lastmod>2005-01-05T12:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/694a4genomed_diabetes_program_engaged_by_michigan_indian_tr/</loc>
		<lastmod>2005-01-05T12:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a4b9vaxgen_restructures_celltrion_agree/</loc>
		<lastmod>2005-01-05T12:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d6480genaera_eye_drug_selected_for_fda_prog/</loc>
		<lastmod>2005-01-05T12:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c3481stemcells_submits_milestone_cns_filing_in_batten_di/</loc>
		<lastmod>2005-01-05T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d484acambis_smallpox_vaccine_fasttr/</loc>
		<lastmod>2005-01-06T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b48bentremeds_new_anticancer_formulation_enters_pha/</loc>
		<lastmod>2005-01-06T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664a2sangamo_and_pfizer_forge_protein_research_collabor/</loc>
		<lastmod>2005-01-06T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/184a1gendata_and_amgen_announce_genetics/</loc>
		<lastmod>2005-01-06T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb4a6valeant_parkinsons_tablet_approaches_fda_app/</loc>
		<lastmod>2005-01-06T10:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9448bmanhattan_pharmaceuticals_and_tarpan_therapeutics_to_/</loc>
		<lastmod>2005-01-06T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b7483researchers_say_antibiotics_may_slow_lou_gehrigs_progre/</loc>
		<lastmod>2005-01-06T11:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/48494immunomedics_lupus_therapy_fasttr/</loc>
		<lastmod>2005-01-06T11:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e9487macromed_licenses_anticancer_product_to_d/</loc>
		<lastmod>2005-01-06T11:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f74basankyo_and_metabasis_diabetes_drug_begins_phase_iib_/</loc>
		<lastmod>2005-01-06T11:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b84a3studies_show_pfizers_lipitor_reduces_p/</loc>
		<lastmod>2005-01-06T11:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e498pg_and_taigen_sign_novel_antibiotic/</loc>
		<lastmod>2005-01-06T12:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d4a3polymedix_secures_funding_for_novel_antib/</loc>
		<lastmod>2005-01-06T12:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c48dnovartis_and_infinity_announce_small_molecule_collabor/</loc>
		<lastmod>2005-01-07T03:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e94a8panacos_novel_hiv_drug_gets_fast_track_design/</loc>
		<lastmod>2005-01-07T06:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be4a6savient_and_orca_sign_breast_cancer_marketing/</loc>
		<lastmod>2005-01-07T09:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a4a2aeterna_zentaris_enters_us_market_via_echelo/</loc>
		<lastmod>2005-01-07T09:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a64b5merck_and_vertex_initiate_phase_i_trial_in_solid_t/</loc>
		<lastmod>2005-01-07T09:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/564b9gemin_x_starts_phase_iii_leukemia_/</loc>
		<lastmod>2005-01-07T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4b0alnylam_grants_genecare_anticancer_li/</loc>
		<lastmod>2005-01-07T09:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac4b8avant_up_on_glaxo_vaccine_f/</loc>
		<lastmod>2005-01-07T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c4b3chemocentryx_antiinflammatory_bowel_drug_enters_pha/</loc>
		<lastmod>2005-01-07T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d4b4cytrx_drug_may_help_reduce_heart_attack_and_stroke_d/</loc>
		<lastmod>2005-01-07T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/944b9coley_reports_encouraging_phase_i_results_in_hepa/</loc>
		<lastmod>2005-01-07T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d54a8biolex_seeks_us_and_uk_approvals_for_anticancer_and_antiviral_pr/</loc>
		<lastmod>2005-01-07T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d24a1scheringploughs_pegintron_also_effective_in_hepati/</loc>
		<lastmod>2005-01-07T10:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64a4paradigm_therapeutics_and_amedis_merge_gain_new_fina/</loc>
		<lastmod>2005-01-07T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/34498pharmaceutical_research_industry_to_publish_more_trial/</loc>
		<lastmod>2005-01-07T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a34b2spectrum_progressing_with_bladder_cancer_/</loc>
		<lastmod>2005-01-10T03:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a485genentechs_updated_avastin_label_fdaapp/</loc>
		<lastmod>2005-01-10T03:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec48bziopharm_and_southern_research_institute_ink_anticancer_research/</loc>
		<lastmod>2005-01-10T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/40483dor_and_cambrex_sign_biodefense_manufacturing/</loc>
		<lastmod>2005-01-10T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/234b1inhibitex_advances_infant_infections_trial/</loc>
		<lastmod>2005-01-10T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d498id_biomedical_cleared_for_us_fluviral_testing_/</loc>
		<lastmod>2005-01-10T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa494schering_ag_down_on_breast_cancer_approval_delay/</loc>
		<lastmod>2005-01-10T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9848fapp_soars_on_breast_cancer_approval/</loc>
		<lastmod>2005-01-10T10:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d649bserono_launches_growth_hormone_deficiency_drug_in_us/</loc>
		<lastmod>2005-01-10T10:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d34abbayer_buys_back_gsk_impotence_drug_rights/</loc>
		<lastmod>2005-01-10T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d349acancer_firms_unite_antisoma_to_acquire_aptamera/</loc>
		<lastmod>2005-01-10T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994b0sustained_benefits_found_with_scheringplough_and_centocors_remicade_/</loc>
		<lastmod>2005-01-10T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51480sanofiaventis_reaffirms_regeneron_oncology_all/</loc>
		<lastmod>2005-01-10T11:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df495sanofiaventis_vaccines_unit_becomes_sanofi_pa/</loc>
		<lastmod>2005-01-10T11:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e649bcomgenex_and_roche_sign_drug_discovery_pact/</loc>
		<lastmod>2005-01-10T11:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1049ealexion_advances_phase_iii_blood_disorder_program_/</loc>
		<lastmod>2005-01-10T12:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/af48dapplied_biosystems_expands_lymphoma_research_collabor/</loc>
		<lastmod>2005-01-11T02:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e4a8sangamo_seeks_approval_for_diabetic_neuropathy_therap/</loc>
		<lastmod>2005-01-11T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe494label_expansion_for_solvay_and_cvs_aceon_gets_priority_r/</loc>
		<lastmod>2005-01-11T11:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e8496invitrogen_to_acquire_zymed_laborat/</loc>
		<lastmod>2005-01-11T11:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc49eisis_restructuring_will_cut_40_of_work/</loc>
		<lastmod>2005-01-11T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a7484human_genome_sciences_cleared_to_begin_clinical_hivaids_trials/</loc>
		<lastmod>2005-01-11T11:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f9496lexicon_advances_cancer_and_bleeding_disorders_programs/</loc>
		<lastmod>2005-01-11T11:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e84a0idenix_extends_hepatitis_trial_on_promising_interim/</loc>
		<lastmod>2005-01-11T11:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef490glaxosmithkline_begins_rotarix_global_launch_/</loc>
		<lastmod>2005-01-11T11:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/64488amphora_and_orthomcneil_enter_inflammatory_disease_pact/</loc>
		<lastmod>2005-01-11T11:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/52493id_biomedical_and_dvc_begin_plague_vaccine_trial/</loc>
		<lastmod>2005-01-11T11:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4b0trubion_begins_first_phase_i_study_in_arthritis/</loc>
		<lastmod>2005-01-11T11:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e3484exelixis_and_glaxosmithkline_amend_collaboration/</loc>
		<lastmod>2005-01-11T11:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884b6xencor_and_chugai_strike_cancer_antibodies_deal/</loc>
		<lastmod>2005-01-11T12:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644a1nabi_attains_encouraging_phase_iii_bloodstream_infections_results/</loc>
		<lastmod>2005-01-11T12:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2349cmillennium_and_jj_begin_phase_iii_velcade_trial/</loc>
		<lastmod>2005-01-11T12:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2148aserono_and_ivax_to_begin_phase_iii_multiple_sclerosis_/</loc>
		<lastmod>2005-01-12T08:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bd48emerck_and_diversa_to_develop_therapeutic_antib/</loc>
		<lastmod>2005-01-12T08:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/374a3sanofiaventis_taxotere_gets_two_new_european_appr/</loc>
		<lastmod>2005-01-12T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a4adacadia_and_sepracor_announce_cns_partnership_/</loc>
		<lastmod>2005-01-12T10:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e491dendreon_down_on_prostate_cancer_trial_failure/</loc>
		<lastmod>2005-01-12T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a74bbtargeted_genetics_and_sirna_form_huntingtons_pact/</loc>
		<lastmod>2005-01-12T10:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa48fvaxin_flu_vaccine_shows_early_promise/</loc>
		<lastmod>2005-01-12T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/654a0major_pharma_firms_launch_drug_discount_card___/</loc>
		<lastmod>2005-01-12T10:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc498proethic_seeks_approval_for_transdermal_antiinflammatory/</loc>
		<lastmod>2005-01-12T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64bccytogen_begins_quadramet_combination_trial_in_multiple_myeloma__/</loc>
		<lastmod>2005-01-12T11:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114b7cytrx_drug_shows_potential_in_diabetes__/</loc>
		<lastmod>2005-01-12T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd48cdyax_antibodies_enter_imclone_cancer_trials/</loc>
		<lastmod>2005-01-12T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/67480raven_biotech_begins_phase_iiia_gastrointestinal_cancers_trial/</loc>
		<lastmod>2005-01-12T11:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b495prometheus_launches_astrazeneca_bowel_capsules/</loc>
		<lastmod>2005-01-12T11:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/11480newrons_pilot_restless_legs_study_proves_succe/</loc>
		<lastmod>2005-01-13T03:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f490pfizer_study_shows_more_patient_health_info_n/</loc>
		<lastmod>2005-01-13T10:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/19496sinovac_hepatitis_ab_vaccine_gets_final_chinese_app/</loc>
		<lastmod>2005-01-13T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e3495myriad_begins_phase_iii_flurizan_alzheimers_/</loc>
		<lastmod>2005-01-13T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d64baamarin_antidepressant_performs_well_in_phase_ii/</loc>
		<lastmod>2005-01-13T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4a9barrier_skin_drugs_show_promise_in_phas/</loc>
		<lastmod>2005-01-13T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/67491locus_and_nci_team_up_to_develop_new_cancer_treat/</loc>
		<lastmod>2005-01-13T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6248ascheringplough_launches_scentfree_nasal_/</loc>
		<lastmod>2005-01-13T11:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8948abristolmyers_squibb_to_sell_otc_business_in_us_and_c/</loc>
		<lastmod>2005-01-13T12:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d148bchiron_anticipates_start_of_manufacturing_facility_remediat/</loc>
		<lastmod>2005-01-13T12:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/40480biovail_pain_drug_formulation_closer_to_app/</loc>
		<lastmod>2005-01-13T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/88492memory_pharma_begins_us_alzheimers_safety_st/</loc>
		<lastmod>2005-01-13T13:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/604a5avanir_and_fda_agree_neurodex_trial_proto/</loc>
		<lastmod>2005-01-13T13:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f748dgenvec_extends_nih_contract_for_hiv_vacci/</loc>
		<lastmod>2005-01-13T13:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/844a2forbes_meditechs_reducol_boosts_profits_and_guida/</loc>
		<lastmod>2005-01-13T13:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/89492sepracors_lunesta_shows_improvement_in_insomniadepression_patient/</loc>
		<lastmod>2005-01-13T13:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0249dcorgentech_files_to_begin_phase_iii_eczema_drug_tr/</loc>
		<lastmod>2005-01-13T13:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524b8decode_seeks_to_move_cardio_compound_into_clinic/</loc>
		<lastmod>2005-01-14T09:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/134bfaceto_to_enter_generic_biopharmaceuticals_market/</loc>
		<lastmod>2005-01-14T09:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba4acbiolinerx_expands_pipeline_with_cancer_hiv_and_inflammatory_therapeutics/</loc>
		<lastmod>2005-01-14T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/40497mylan_retreats_from_king_merger/</loc>
		<lastmod>2005-01-14T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf4b6alpharma_and_synthon_to_copromote_neuro_drug/</loc>
		<lastmod>2005-01-14T09:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e494astrazenecas_zomig_provides_total_migraine_relief_in_study/</loc>
		<lastmod>2005-01-14T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d49eid_biomedical_reports_positive_flu_vaccine_field_results/</loc>
		<lastmod>2005-01-14T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/574bcbristolmyers_squibbmedarex_cancer_deal_becomes_effective/</loc>
		<lastmod>2005-01-14T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5486abgenix_to_receive_amgen_antibody_pa/</loc>
		<lastmod>2005-01-14T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c14a3lilly_defends_itself_against_prozac_allegations/</loc>
		<lastmod>2005-01-14T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c487nanobac_links_nanobacteria_infection_to_atheroscle/</loc>
		<lastmod>2005-01-14T11:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/89492genomed_finds_genes_linked_to_common_ca/</loc>
		<lastmod>2005-01-17T04:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/614bcshireimpax_adhd_generic_dispute_cont/</loc>
		<lastmod>2005-01-17T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/60499onsource_and_osmotics_to_merge/</loc>
		<lastmod>2005-01-17T11:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e4a4roches_avastin_gets_european_approval/</loc>
		<lastmod>2005-01-17T11:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e9484emergent_and_uk_health_agency_sign_vaccine_pact/</loc>
		<lastmod>2005-01-17T11:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e48eicagen_and_abbott_renew_pain_drugs_collaboration/</loc>
		<lastmod>2005-01-17T11:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd4acmercks_mevacor_sale_proposal_rejected_by_fda_panel_/</loc>
		<lastmod>2005-01-17T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f4adsanofiaventis_meningitis_vaccine_licensed_by_fda/</loc>
		<lastmod>2005-01-17T11:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/424b9altana_launches_novel_asthma_treatment_in_uk/</loc>
		<lastmod>2005-01-17T11:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc4acresearchers_find_dna_mutations_key_to_prostate_cancer/</loc>
		<lastmod>2005-01-17T11:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b48bstudy_shows_scheringploughs_pegintron_outcome_affected_by_depression/</loc>
		<lastmod>2005-01-17T11:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4a3ambit_signs_drug_screening_deals_with_glaxo_bms_pfizer/</loc>
		<lastmod>2005-01-17T11:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d248fpropharmaceuticals_phase_i_cancer_trial_progressing/</loc>
		<lastmod>2005-01-17T11:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/394b5labopharm_up_on_french_pain_drug/</loc>
		<lastmod>2005-01-17T11:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e5486warner_chilcott_lowdose_femhrt_fdaapp/</loc>
		<lastmod>2005-01-18T03:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b948eshire_outlicenses_hiv_compound_to_avexa/</loc>
		<lastmod>2005-01-18T10:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f4a5globeimmune_and_mycologics_enter_antifungal_deal/</loc>
		<lastmod>2005-01-18T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd48dppd_acquires_surromed_biomarker_assets/</loc>
		<lastmod>2005-01-18T10:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d0483study_shows_benefits_of_child_sleep_apnea_treatments_/</loc>
		<lastmod>2005-01-18T10:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a749eresearch_suggests_explanation_for_skin_cancer_vaccine_success/</loc>
		<lastmod>2005-01-18T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce494study_shows_combo_therapy_boosts_cancer_treatment/</loc>
		<lastmod>2005-01-18T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5449cstudy_identifies_most_common_genetic_cause_of_parkinsons/</loc>
		<lastmod>2005-01-18T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224bcpenn_researchers_highlight_further_evidence_of_bextra_heart_risk/</loc>
		<lastmod>2005-01-18T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d4bcwyeth_diet_drugs_case_approaches_settlement/</loc>
		<lastmod>2005-01-18T11:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474b6albany_establishes_singapore_research_centre/</loc>
		<lastmod>2005-01-18T11:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce4bemaxim_down_on_extra_leukemia_trial_request/</loc>
		<lastmod>2005-01-18T11:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4bfsanofiaventis_launches_ypsomed_insulin_pen/</loc>
		<lastmod>2005-01-18T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/53499aeterna_zentaris_advances_novel_anticancer_agent_into_c/</loc>
		<lastmod>2005-01-19T04:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d9484compound_raises_155_million_for_cancer_products/</loc>
		<lastmod>2005-01-19T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/194a3adherex_cleared_to_begin_european_advanced_cancer_trial/</loc>
		<lastmod>2005-01-19T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd4a1spectrum_to_get_us_patent_for_bladder_cancer_drug/</loc>
		<lastmod>2005-01-19T10:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a49fchemdiv_and_greenebaum_cancer_center_sign_breast_cancer_pact/</loc>
		<lastmod>2005-01-19T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e1481orphan_seeks_to_expand_xyrem_narcolepsy_label/</loc>
		<lastmod>2005-01-19T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b1494alteon_moves_erectile_dysfunction_drug_into_phase_ii/</loc>
		<lastmod>2005-01-19T10:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e2496osi_uk_unit_begins_phase_ii_antidiabetes_trial/</loc>
		<lastmod>2005-01-19T10:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db491cogtest_and_netmet_to_enhance_cognitive_impairment_trials/</loc>
		<lastmod>2005-01-19T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/48495scientists_find_potential_new_target_for_obesity_and_diabetes_treatments/</loc>
		<lastmod>2005-01-19T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/48486oxford_biomedica_soars_on_merger_talks/</loc>
		<lastmod>2005-01-19T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4948fgw_pharmas_sativex_performs_well_in_cancer_pain/</loc>
		<lastmod>2005-01-19T11:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e484genvec_hiv_vaccine_enters_second_phase_i_trial/</loc>
		<lastmod>2005-01-20T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ab498entremeds_panzem_shows_promise_in_head_and_neck_cancer/</loc>
		<lastmod>2005-01-20T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/53496adenosine_and_orthomcneil_to_develop_novel_diabetes_and_asthma_drugs/</loc>
		<lastmod>2005-01-20T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e049dseattle_genetics_anticancer_program_gets_two_us_patents/</loc>
		<lastmod>2005-01-20T11:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4bbid_biomedical_developing_pandemic_influenza_vaccine/</loc>
		<lastmod>2005-01-20T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e949bastrazenecas_exanta_suffers_european_setback/</loc>
		<lastmod>2005-01-20T11:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6487sention_to_develop_merck_compounds_for_mental_retardation/</loc>
		<lastmod>2005-01-20T11:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e0497european_commission_fines_mcaa_chemicals_cartel/</loc>
		<lastmod>2005-01-20T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/634a5cotherix_selects_pharmacy_outlet_accredo_to_stock_its_hypertension_treatment/</loc>
		<lastmod>2005-01-20T11:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/81490nicox_progressing_with_artery_disease_trial/</loc>
		<lastmod>2005-01-20T11:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a9483yamanouchi_and_gsk_launch_incontinence_drug_in_us_/</loc>
		<lastmod>2005-01-20T11:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a481morphosys_acquires_uk_and_us_antibodies_/</loc>
		<lastmod>2005-01-20T11:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d4bcrigel_and_pfizer_join_to_fight_respiratory_dis/</loc>
		<lastmod>2005-01-21T04:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e449ephytopharm_alzheimers_study_clears_safety_review/</loc>
		<lastmod>2005-01-21T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae4a8allos_begins_phase_i_dosing_study_for_lung_cancer_drug/</loc>
		<lastmod>2005-01-21T09:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/194a4genvec_expands_us_malaria_vaccine_program/</loc>
		<lastmod>2005-01-21T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/af49anovartis_q4_brings_mixed_fortunes/</loc>
		<lastmod>2005-01-21T09:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4a3pfizer_cox2s_help_boost_2004_profits/</loc>
		<lastmod>2005-01-21T09:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/354a2pfizers_onesal_cox2_denied_eu_launch/</loc>
		<lastmod>2005-01-21T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/75492bolder_biotech_gets_grant_for_novel_arthritis_treatment/</loc>
		<lastmod>2005-01-21T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec492medimmune_files_to_move_respiratory_vaccine_into_clinic/</loc>
		<lastmod>2005-01-21T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f497manhattans_antiobesity_product_cleared_for_human_testing/</loc>
		<lastmod>2005-01-21T09:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e948fscheringplough_to_acquire_neogenesis_assets/</loc>
		<lastmod>2005-01-21T09:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4a2pfizer_to_acquire_private_eye_disease/</loc>
		<lastmod>2005-01-21T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/004b2cipher_to_sell_research_services_unit/</loc>
		<lastmod>2005-01-24T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444b9peregrine_brain_cancer_trial_protocol_approved/</loc>
		<lastmod>2005-01-24T10:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df493pfizers_geodon_may_outshine_risperdal_in_schizophrenia/</loc>
		<lastmod>2005-01-24T10:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/604afcourt_rules_in_pfizers_favor_over_zoloft_patent/</loc>
		<lastmod>2005-01-24T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644a3shire_suffers_on_jj_drug_death_worries/</loc>
		<lastmod>2005-01-24T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5548bpharmos_gets_12_million_for_eye_treatment_milestone/</loc>
		<lastmod>2005-01-24T10:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/13494pfizers_viagra_effectively_treats_heart_condition_in_study_/</loc>
		<lastmod>2005-01-24T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf4aaresearchers_find_steroids_increase_death_risk_in_head_injuries/</loc>
		<lastmod>2005-01-24T10:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd48bserono_progressing_with_hivassociated_syndrome_trial/</loc>
		<lastmod>2005-01-24T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/294a4karo_bio_meets_merck_development_milestone/</loc>
		<lastmod>2005-01-24T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c94b7perlegen_and_astrazeneca_sign_new_genome_deal_/</loc>
		<lastmod>2005-01-24T11:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4b8merck_begins_collaborative_phase_ii_hiv_trial/</loc>
		<lastmod>2005-01-24T11:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224a5vasogen_neuro_drug_cleared_for_c/</loc>
		<lastmod>2005-01-25T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/96497novogen_anticancer_drug_significantly_boosts_tax/</loc>
		<lastmod>2005-01-25T11:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f0498study_confirms_longterm_safety_of_astrazeneca_migraine_/</loc>
		<lastmod>2005-01-25T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b94b8lilly_icos_cialis_gets_bass_sponsorship/</loc>
		<lastmod>2005-01-25T11:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f4b9scolr_pharma_ibuprofen_trial_gets_f/</loc>
		<lastmod>2005-01-25T11:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/01499chemgenex_raises_62_million_for_anticancer_comp/</loc>
		<lastmod>2005-01-25T11:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca485jj_seeks_us_approval_for_leukemia/</loc>
		<lastmod>2005-01-25T11:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b24bfranbaxy_seeks_who_approval_for_antihiv_a/</loc>
		<lastmod>2005-01-25T11:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f481genzyme_sues_to_stop_tkt_/</loc>
		<lastmod>2005-01-25T11:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f649dschering_ag_and_novartis_to_copromote_anticancer_pr/</loc>
		<lastmod>2005-01-26T02:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74a9novel_neuro3d_antidepressant_enters_c/</loc>
		<lastmod>2005-01-26T02:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594b3nektar_and_zelos_to_develop_osteoporosis_th/</loc>
		<lastmod>2005-01-26T02:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d04a7bayer_and_nektar_to_develop_lung_antib/</loc>
		<lastmod>2005-01-26T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/964b1alnylam_up_on_spinal_chord_therapy_/</loc>
		<lastmod>2005-01-26T10:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f54a9millennium_and_ucb_pharma_sign_inflammation_agre/</loc>
		<lastmod>2005-01-26T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5487metabasis_and_merck_extend_hepatitis_c_agre/</loc>
		<lastmod>2005-01-26T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a04a1ym_biosciences_up_on_brain_cancer_trial_pro/</loc>
		<lastmod>2005-01-26T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f481aeterna_zentaris_subsidiary_acquires_mult/</loc>
		<lastmod>2005-01-26T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064a6biovail_launches_bedtime_blood_pressure_trea/</loc>
		<lastmod>2005-01-26T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df487adventrx_up_on_cancer_study_su/</loc>
		<lastmod>2005-01-26T11:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4a8wyeth_and_takeda_arthritis_treatment_gets_japane/</loc>
		<lastmod>2005-01-26T11:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e48epozen_migraine_tablet_issued_european_p/</loc>
		<lastmod>2005-01-26T11:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd4b0pdl_to_acquire_esp_p/</loc>
		<lastmod>2005-01-26T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a491transition_therapeutics_expands_diabetes_t/</loc>
		<lastmod>2005-01-26T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d14b2morphosys_and_bristolmyers_expand_drug_development_relationshi/</loc>
		<lastmod>2005-01-27T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f74aemylinax_targeted_to_become_first_oral_therapy_for_multiple_sclerosi/</loc>
		<lastmod>2005-01-27T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6548aimclone_rises_on_news_of_licensing_deal/</loc>
		<lastmod>2005-01-27T11:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4a8gtx_initiates_pivotal_prostate_cancer_stud/</loc>
		<lastmod>2005-01-27T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f49bprocyon_restructuring_brings_change_of_fo/</loc>
		<lastmod>2005-01-27T11:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b7486nastech_and_merck_to_test_obesity_treatme/</loc>
		<lastmod>2005-01-27T11:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3948bmarshall_edwards_prostate_cancer_drug_gains_fast_track_sta/</loc>
		<lastmod>2005-01-27T11:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b24b1novartis_breast_cancer_tablets_beat_rival_drug_in_/</loc>
		<lastmod>2005-01-28T03:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a849cfda_approves_hookworm_vaccine_t/</loc>
		<lastmod>2005-01-28T03:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4b3gsk_tax_dispute_widens_with_19_billion_n/</loc>
		<lastmod>2005-01-28T03:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/484adpropharmaceuticals_anticancer_treatment_welltolerated_in_ph/</loc>
		<lastmod>2005-01-28T10:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec480cytogen_and_sanofiaventis_anticancer_combination_to_be_t/</loc>
		<lastmod>2005-01-28T10:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c648bsonus_taxol_rival_gets_orphan_drug_s/</loc>
		<lastmod>2005-01-28T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/454b7gb_thera_acquires_parkinsons_compound/</loc>
		<lastmod>2005-01-28T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a548abmj_retracts_prozac_risk_allegations/</loc>
		<lastmod>2005-01-28T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e498danisco_to_expand_enzymes_business_with_genencor_purchase/</loc>
		<lastmod>2005-01-28T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/32491transport_and_gsk_sign_cold_sore_drug_delivery_deal/</loc>
		<lastmod>2005-01-28T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3648fperegrine_cleared_to_proceed_with_tarvacin_program/</loc>
		<lastmod>2005-01-28T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214a5genentechs_avastin_improves_survival_in_combination_study/</loc>
		<lastmod>2005-01-28T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/164b3osis_tarceva_betters_standard_of_care_in_pancreatic_cancer/</loc>
		<lastmod>2005-01-28T10:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be4b9teva_gets_final_approval_for_generic_antib/</loc>
		<lastmod>2005-01-28T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/80483cat_up_on_24_million_abbott_p/</loc>
		<lastmod>2005-01-31T11:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc48anti_antistroke_drug_fasttracked/</loc>
		<lastmod>2005-01-31T11:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/204acneose_and_biogenerix_sign_second_protein/</loc>
		<lastmod>2005-01-31T11:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a34b6wyeth_antibiotic_gets_priority_review_status/</loc>
		<lastmod>2005-01-31T11:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5749amerck_reeling_from_fosamax_vioxx_woes/</loc>
		<lastmod>2005-01-31T11:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/36488aspirin_could_treat_diabetes_researchers_say/</loc>
		<lastmod>2005-01-31T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f497transition_progressing_with_phase_ii_multiple_sclerosis_trial/</loc>
		<lastmod>2005-01-31T11:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4badurect_and_voyager_moving_ahead_with_alzheimers_trial_/</loc>
		<lastmod>2005-01-31T11:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc48eym_biosciences_expands_lead_anticancer_program/</loc>
		<lastmod>2005-01-31T11:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f48dsanofiaventis_reports_positive_eloxatinavastin_results/</loc>
		<lastmod>2005-01-31T11:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e7493schwarz_pharma_resubmits_us_neupro_application/</loc>
		<lastmod>2005-01-31T11:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c44b9shire_and_new_river_to_comarket_latestage_adhd_drug/</loc>
		<lastmod>2005-02-01T10:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47481flamel_and_bms_resolve_basulin_licensing_issues/</loc>
		<lastmod>2005-02-01T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/774a5cortex_to_begin_phase_ii_alzheimers_trial/</loc>
		<lastmod>2005-02-01T10:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c4bcmedicure_to_develop_novel_cholesterol_drugs/</loc>
		<lastmod>2005-02-01T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a948fabbotts_humira_beats_remicade_in_crohns_study/</loc>
		<lastmod>2005-02-01T10:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb4a6roches_valcyte_recommended_in_aidsrelated_eye_disease/</loc>
		<lastmod>2005-02-01T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c94b1wyeth_diet_drugs_slim_financial_pickings/</loc>
		<lastmod>2005-02-01T11:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/244bbiomai_gets_29_million_to_develop_influenza_vaccine_/</loc>
		<lastmod>2005-02-01T11:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf48eangiogenix_drug_disappoints_in_phase_ii_angina_study/</loc>
		<lastmod>2005-02-01T12:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824b7northwest_biotherapeutics_soars_on_prostate_cancer_tri/</loc>
		<lastmod>2005-02-02T02:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/704a8biomarins_enzyme_therapy_granted_sixmonth_fda_r/</loc>
		<lastmod>2005-02-02T02:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/784a9palatin_small_molecule_performs_well_in_obesity_/</loc>
		<lastmod>2005-02-02T02:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214begpc_biotech_begins_phase_i_lymphoma_/</loc>
		<lastmod>2005-02-02T02:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b3487sanofiaventis_and_glaxo_drugs_could_halt_huntingtons_di/</loc>
		<lastmod>2005-02-02T02:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe499curagen_and_topotarget_blood_cancer_treatment_enters_pha/</loc>
		<lastmod>2005-02-02T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f74abaeterna_zentaris_subsidiary_to_develop_comgenex_cancer_comp/</loc>
		<lastmod>2005-02-02T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6148eesp_pharma_acquires_centocor_heart/</loc>
		<lastmod>2005-02-02T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/694a9stemcells_first_clinical_trial_halted_by_fda/</loc>
		<lastmod>2005-02-02T10:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d493forbes_meditech_begins_cholesterol_drug_toxicity_study/</loc>
		<lastmod>2005-02-02T10:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d48ccuris_and_genentech_to_codevelop_skin_cancer_drug/</loc>
		<lastmod>2005-02-02T10:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/60487millenniums_velcade_shows_promise_in_lymphoma_studies/</loc>
		<lastmod>2005-02-02T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c7495nastech_up_on_second_fda_approval_/</loc>
		<lastmod>2005-02-02T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b494pfizer_defends_celebrex_risk_disclosure/</loc>
		<lastmod>2005-02-02T11:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1348branbaxy_cleared_to_market_generic_antiinfe/</loc>
		<lastmod>2005-02-02T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/134afvaleant_to_acquire_private_neurology/</loc>
		<lastmod>2005-02-02T11:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/75486par_to_market_generic_hypertension_tablets/</loc>
		<lastmod>2005-02-02T11:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f4b3renovis_progressing_with_phase_ii_pain_study/</loc>
		<lastmod>2005-02-02T11:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4b1hana_biosciences_begins_phase_iii_lung_cancer_trial/</loc>
		<lastmod>2005-02-02T11:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264a8savient_and_novo_nordisk_reach_partial_hormone_settlement/</loc>
		<lastmod>2005-02-02T11:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d049dpfizer_and_schering_ag_sign_thrombosis_license_deal/</loc>
		<lastmod>2005-02-02T11:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/91494anadys_hepatitis_candidate_enters_clinic/</loc>
		<lastmod>2005-02-03T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d1485kyorin_closes_activx_bio_takeover/</loc>
		<lastmod>2005-02-03T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/37494argos_receives_1_million_lupus_grant/</loc>
		<lastmod>2005-02-03T09:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed49egenerex_reports_encouraging_oral_insulin_results/</loc>
		<lastmod>2005-02-03T09:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce4aexcyte_leukemia_trial_to_face_delay/</loc>
		<lastmod>2005-02-03T10:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f44b1merck_added_to_medimmunegsk_cancer_vaccine_deal/</loc>
		<lastmod>2005-02-03T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a04admyogen_shares_nosedive_on_hypertension_trial_delay/</loc>
		<lastmod>2005-02-03T11:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f483ino_and_forest_to_copromote_lung_medication/</loc>
		<lastmod>2005-02-03T11:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed48ascientists_find_promising_nerve_tumor_ta/</loc>
		<lastmod>2005-02-03T12:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f84adresearch_indicates_injection_matches_surgery_in_carpal_tunnel_syndrome/</loc>
		<lastmod>2005-02-03T12:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b9489gsks_bexxar_could_oust_lymphoma_chemotherapy/</loc>
		<lastmod>2005-02-03T12:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/00487basilea_and_jj_enter_global_antibiotic_deal/</loc>
		<lastmod>2005-02-03T12:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/324b9speedel_progressing_with_nextgen_antihypertensives/</loc>
		<lastmod>2005-02-03T12:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf49bschering_ag_introduces_new_dermatology_specialist/</loc>
		<lastmod>2005-02-04T03:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064a2aptamera_acquisition_gets_shareholder_app/</loc>
		<lastmod>2005-02-04T03:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a64b4virologic_to_support_gsk_hiv_pro/</loc>
		<lastmod>2005-02-04T04:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b84beprocyon_hiv_treatment_beats_major_rivals_in_study/</loc>
		<lastmod>2005-02-04T08:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6490vasogen_inflammation_drug_enters_clinic/</loc>
		<lastmod>2005-02-04T09:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/084aeuk_regulators_warn_of_strattera_liver_risks/</loc>
		<lastmod>2005-02-04T09:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed4b5gilead_and_bms_hiv_combo_beats_glaxo_rival/</loc>
		<lastmod>2005-02-04T09:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8649ecoleys_promune_shows_promise_in_lung_cancer_/</loc>
		<lastmod>2005-02-04T09:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d648btb_alliance_gets_e2_million_further_funding/</loc>
		<lastmod>2005-02-04T09:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b498nitromed_heart_drug_resubmission_accepted_by_fd/</loc>
		<lastmod>2005-02-04T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734a6enzon_stops_cancer_program_reports_q2_loss/</loc>
		<lastmod>2005-02-04T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44a2glaxo_heart_drug_ad_slammed_by_fda/</loc>
		<lastmod>2005-02-04T10:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/84497viventias_anticancer_candidate_granted_orphan_drug_status/</loc>
		<lastmod>2005-02-04T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f486repligen_schizophrenia_treatment_disappoints_in_pha/</loc>
		<lastmod>2005-02-07T08:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f4a7oxigene_compound_shows_early_promise_in_eye_t/</loc>
		<lastmod>2005-02-07T08:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094afnovavax_sars_vaccine_gets_nih_fu/</loc>
		<lastmod>2005-02-07T08:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b94bcviragen_seeks_expanded_multiferon_app/</loc>
		<lastmod>2005-02-07T11:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f54aabarr_sues_fda_over_allergy_drug_r/</loc>
		<lastmod>2005-02-07T11:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba4bdnovartis_and_merck_cox2s_join_fda_review/</loc>
		<lastmod>2005-02-07T11:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c44a4researchers_call_for_further_studies_in_shingles_va/</loc>
		<lastmod>2005-02-07T11:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/874b6abbott_oral_therapy_rivals_intravenous_app/</loc>
		<lastmod>2005-02-07T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4a5canada_funds_tamiflu_stockpile_pur/</loc>
		<lastmod>2005-02-07T11:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b4a8axonyx_plummets_on_alzheimers_trial_fa/</loc>
		<lastmod>2005-02-07T11:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee484vicuron_antifungal_beats_pfizer_rival_in_phas/</loc>
		<lastmod>2005-02-08T02:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d84addr_reddys_cardio_drug_enters_first_european_/</loc>
		<lastmod>2005-02-08T02:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c3496takeda_to_expand_us_operations_with_syrr/</loc>
		<lastmod>2005-02-08T02:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1749cportola_moves_oral_anticoagulant_into_clinical_trial/</loc>
		<lastmod>2005-02-08T10:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c499atugen_and_asinex_enter_cancer_discovery_deal/</loc>
		<lastmod>2005-02-08T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef48dtripos_to_enhance_biotie_drug_discovery_/</loc>
		<lastmod>2005-02-08T10:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c44aesanofiaventis_cleared_to_marketcancer_jab/</loc>
		<lastmod>2005-02-08T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b480targeted_genetics_expands_hiv_program_into_india/</loc>
		<lastmod>2005-02-08T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/434abjds_and_synthon_to_copromote_bipolar_drug/</loc>
		<lastmod>2005-02-08T10:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b4a5dor_biopharma_begins_rivax_human_testing/</loc>
		<lastmod>2005-02-08T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a4begsk_to_launch_cfcfree_inhaler/</loc>
		<lastmod>2005-02-08T11:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb49ejj_ovarian_cancer_drug_gets_full_fda_ok/</loc>
		<lastmod>2005-02-08T11:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c4afhemispherx_expands_bird_flu_studies/</loc>
		<lastmod>2005-02-08T11:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014adnps_to_delay_us_preos_filing/</loc>
		<lastmod>2005-02-08T11:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a64b9kos_expands_research_efforts_with_triad_investment/</loc>
		<lastmod>2005-02-08T11:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a48dligand_earns_1_million_for_gsk_platelet_trials/</loc>
		<lastmod>2005-02-08T11:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/02494lilly_introduces_barcoding_on_insulin_/</loc>
		<lastmod>2005-02-09T02:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b4a1barrier_gets_north_american_rights_for_skin_trea/</loc>
		<lastmod>2005-02-09T02:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/70496methylgene_and_envivo_sign_neuro_therapeutics_deal/</loc>
		<lastmod>2005-02-09T10:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3f4bccorixa_up_on_gsk_hepatitis_approval/</loc>
		<lastmod>2005-02-09T10:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c4aalorus_cancer_trial_progressing_after_review/</loc>
		<lastmod>2005-02-09T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b4b3alba_therapeutics_reports_breakthrough_diabetes_results/</loc>
		<lastmod>2005-02-09T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474a2auxilium_expands_into_pain_care_with_pharm/</loc>
		<lastmod>2005-02-09T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b4bcdpharm_begins_phase_iib_stroke_study/</loc>
		<lastmod>2005-02-09T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984a2genzyme_buys_verigen_to_boost_orthopedic_offering/</loc>
		<lastmod>2005-02-09T11:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1748dpfizer_reports_cancer_trial_triumph_job_cuts_predicted/</loc>
		<lastmod>2005-02-09T11:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff4a4quark_and_sanwa_sign_dyslipidemia_licensing_deal/</loc>
		<lastmod>2005-02-09T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4aachemgenex_quinamed_shows_promise_in_cancer_trials/</loc>
		<lastmod>2005-02-09T11:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/75499amersin_subsidiary_secures_new_ribavirin_contract/</loc>
		<lastmod>2005-02-09T11:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6499alfacell_expands_onconase_lung_cancer_program/</loc>
		<lastmod>2005-02-09T11:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf48fmaxim_cuts_jobs_after_more_ceplene_failures/</loc>
		<lastmod>2005-02-09T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3648amerck_accused_of_ignoring_mercury_dangers/</loc>
		<lastmod>2005-02-09T11:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a34bbglobalnet_to_help_fda_simplify_drug_approval_pr/</loc>
		<lastmod>2005-02-09T11:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24b0albany_and_lilly_renew_research/</loc>
		<lastmod>2005-02-09T13:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e8488sinovac_increases_stake_in_beijing_unit/</loc>
		<lastmod>2005-02-10T10:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b483paringenix_heart_drug_approved_for_clinic_/</loc>
		<lastmod>2005-02-10T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/33493west_pharmaceutical_sells_drug_delivery_business/</loc>
		<lastmod>2005-02-10T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/004aahana_bios_zofran_rival_enters_new_trial/</loc>
		<lastmod>2005-02-10T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d4a6medtronic_and_alnylam_form_neuro_treatments_pact/</loc>
		<lastmod>2005-02-10T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384bdforest_begins_confirmatory_study_of_vampire_bat_drug/</loc>
		<lastmod>2005-02-10T11:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8848dbarr_wins_court_battle_over_antidiuretic/</loc>
		<lastmod>2005-02-11T03:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/704bdactivx_bio_and_pfizer_expand_strategic_collabor/</loc>
		<lastmod>2005-02-11T03:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144b6generex_gets_patent_for_pain_relief_del/</loc>
		<lastmod>2005-02-11T03:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de481chemgenex_licenses_groundbreaking_anticancer_/</loc>
		<lastmod>2005-02-11T03:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8048emeridian_bioscience_enters_biodefense_m/</loc>
		<lastmod>2005-02-11T03:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d3488critical_thera_up_on_rhodia_asthma_agre/</loc>
		<lastmod>2005-02-11T03:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/514abboehringer_ingelheim_halts_immunogen_anticancer_pr/</loc>
		<lastmod>2005-02-11T03:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/98481shire_suffers_on_canadian_adderall_xr_sales_suspe/</loc>
		<lastmod>2005-02-11T07:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a7485akesis_awarded_us_patent_for_diabetes_treat/</loc>
		<lastmod>2005-02-11T07:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa4b9gsk_down_in_2004_upbeat_for_2005/</loc>
		<lastmod>2005-02-11T09:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c6491lilly_icos_buoyed_by_pfizer_patent_r/</loc>
		<lastmod>2005-02-11T09:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4aewellgen_and_hmgene_forge_obesity/</loc>
		<lastmod>2005-02-11T09:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474b3cephalon_shares_stir_on_sleep_drug_/</loc>
		<lastmod>2005-02-11T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224bedurect_progressing_with_pain_relief_programs/</loc>
		<lastmod>2005-02-11T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b6486pfizer_and_microsoft_target_viagra_spammers/</loc>
		<lastmod>2005-02-11T09:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/19493vical_melanoma_trial_design_gets_fda_approval/</loc>
		<lastmod>2005-02-11T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a499generex_to_develop_safer_smallpox_vaccine/</loc>
		<lastmod>2005-02-11T09:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144b3novo_nordisk_divests_ferrosan_shareholding/</loc>
		<lastmod>2005-02-11T09:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4a4isotechnika_expands_phase_iii_psoriasis_trial/</loc>
		<lastmod>2005-02-11T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/934bbbioveris_completes_nrc_vaccine_agreement/</loc>
		<lastmod>2005-02-11T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8349ecambria_neuro_research_gets_nih_funding_/</loc>
		<lastmod>2005-02-14T08:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3f48dastrazeneca_migraine_spray_brings_rapid_relief_/</loc>
		<lastmod>2005-02-14T09:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/424bbivax_and_alpharma_settle_epilepsy_generic_suit/</loc>
		<lastmod>2005-02-14T09:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db480cardiome_up_on_heart_failure_trial_success/</loc>
		<lastmod>2005-02-14T09:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4abamgen_confirms_parkinsons_drug_risks_/</loc>
		<lastmod>2005-02-14T09:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/754aegenvec_cleared_to_resume_cancer_studies/</loc>
		<lastmod>2005-02-14T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a48cteva_and_savient_launch_growth_hormone_product_in_us/</loc>
		<lastmod>2005-02-14T09:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/92491fda_to_file_abbotts_xinlay_submission_/</loc>
		<lastmod>2005-02-14T09:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc4b5soseixenova_drug_granted_orphan_status_in_japan/</loc>
		<lastmod>2005-02-14T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f4b2fda_pfizer_and_merck_keep_cox2_debate_bubbling/</loc>
		<lastmod>2005-02-14T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d481ucla_scientists_show_hiv_can_target_cancer/</loc>
		<lastmod>2005-02-14T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e5488breast_cancer_drug_reduces_heart_risk_study_shows/</loc>
		<lastmod>2005-02-14T10:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e4b1encysive_rises_on_thelin_trial_success/</loc>
		<lastmod>2005-02-15T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314ackosanroche_compound_enters_phase_ii_prostate_cancer_trial/</loc>
		<lastmod>2005-02-15T09:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae4afisis_licenses_anticancer_drug_to_sarissa/</loc>
		<lastmod>2005-02-15T09:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d3486theraquest_unveils_safer_pain_drug_formulation/</loc>
		<lastmod>2005-02-15T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b48dambit_research_suggests_new_uses_for_key_cancer_drugs/</loc>
		<lastmod>2005-02-15T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b4bboxigene_compound_enhances_avastins_efficacy/</loc>
		<lastmod>2005-02-15T10:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c499pfizers_lyrica_halves_seizures_in_epilepsy_study/</loc>
		<lastmod>2005-02-15T10:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/484a3renovis_multiple_sclerosis_compound_enters_clinic/</loc>
		<lastmod>2005-02-15T12:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4aftevas_agilect_improves_symptoms_in_parkinsons_study/</loc>
		<lastmod>2005-02-15T12:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/69495medicis_psoriasis_treatment_gets_fda_app/</loc>
		<lastmod>2005-02-16T02:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae49b4sc_lands_japanese_discovery_deal/</loc>
		<lastmod>2005-02-16T10:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314b8aphton_sinks_on_cancer_trial_failure/</loc>
		<lastmod>2005-02-16T10:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e9483siga_smallpox_program_gets_27_million_funding/</loc>
		<lastmod>2005-02-16T10:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a7481avalon_to_develop_vertex_cancer_agent/</loc>
		<lastmod>2005-02-16T10:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51480fda_to_create_drug_safety_board/</loc>
		<lastmod>2005-02-16T10:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a8496point_melanoma_treatment_shows_promise_in_phase_ii/</loc>
		<lastmod>2005-02-16T10:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/024beseattle_genetics_and_curagen_extend_antibody_deal/</loc>
		<lastmod>2005-02-16T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/89482serono_partner_achieves_key_drug_discovery_milestone/</loc>
		<lastmod>2005-02-16T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/244b3entelos_and_organon_extend_arthritis_pact/</loc>
		<lastmod>2005-02-16T10:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd4b7cornerstone_and_adams_pen_product_transfer_deal/</loc>
		<lastmod>2005-02-16T10:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/404b5fda_accepts_solvays_aceon_submission/</loc>
		<lastmod>2005-02-16T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4b2cangene_antibody_shines_in_fever_trial/</loc>
		<lastmod>2005-02-16T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d84b7genaera_progressing_with_eye_drug_t/</loc>
		<lastmod>2005-02-17T02:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/454afdiatos_cancer_program_gets_flemish_government_grant/</loc>
		<lastmod>2005-02-17T08:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d34b8anormed_selects_evotec_services_for_phase_iii_compound_/</loc>
		<lastmod>2005-02-17T08:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/324b0neurocrine_insomnia_drug_continues_to_impress/</loc>
		<lastmod>2005-02-17T08:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4848asigmaaldrich_genomics_to_be_boosted_by_proglio_purchase/</loc>
		<lastmod>2005-02-17T09:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384a2merck_launches_wireless_format_for_online_medical_res/</loc>
		<lastmod>2005-02-17T09:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a04a1durect_moves_pain_patch_into_phase_ii/</loc>
		<lastmod>2005-02-17T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a482biolex_and_octoplus_to_codevelop_hepatitis_drug/</loc>
		<lastmod>2005-02-17T10:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e48aalpharx_nsaid_to_enter_clini/</loc>
		<lastmod>2005-02-17T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4a9bioenvision_moves_hepatitis_agent_into_phase_ii/</loc>
		<lastmod>2005-02-17T10:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b4484celsion_progressing_with_heatactivated_cancer_drug_trial/</loc>
		<lastmod>2005-02-17T10:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4b5affinium_selects_superbugs_antibiotic_candidat/</loc>
		<lastmod>2005-02-17T11:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f34b0teva_and_gamidacell_enter_leukemia_venture/</loc>
		<lastmod>2005-02-17T11:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a94a6vivus_makes_headway_in_beginning_avanafil_/</loc>
		<lastmod>2005-02-18T04:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5248asanofiaventis_and_qlt_launch_sixmonth_eligard/</loc>
		<lastmod>2005-02-18T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/96490biogen_and_elans_tsyabri_shines_in_phase_iii/</loc>
		<lastmod>2005-02-18T07:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594aeucb_pharma_child_epilepsy_drug_gets_priority_review/</loc>
		<lastmod>2005-02-18T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e496dendreons_provenge_sets_record_survival_benefit/</loc>
		<lastmod>2005-02-18T07:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4aatheraquest_hiv_pain_drug_granted_orphan_status/</loc>
		<lastmod>2005-02-18T07:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4bdadenosine_thera_receives_grant_for_parkinsons_research/</loc>
		<lastmod>2005-02-18T07:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e249eglaxo_and_teva_settle_lamictal_suit/</loc>
		<lastmod>2005-02-18T07:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51482boehringer_drug_could_match_vioxx_risks_scientist_say/</loc>
		<lastmod>2005-02-18T07:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b498chemgenex_cancer_drug_to_get_european_patent/</loc>
		<lastmod>2005-02-18T07:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d6499pharmamar_anticancer_agent_enters_phase_ii_t/</loc>
		<lastmod>2005-02-18T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b486topigen_initiates_phase_i_asthma_/</loc>
		<lastmod>2005-02-18T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0348aemea_announces_cox2_restric/</loc>
		<lastmod>2005-02-18T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/31491oncolytics_up_on_uk_trial_ok/</loc>
		<lastmod>2005-02-21T09:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a48dgenmab_antibody_shows_lasting_responses_in_skin_cance/</loc>
		<lastmod>2005-02-21T09:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f04a4eli_lillys_cymbalta_heading_for_another_euro_approval/</loc>
		<lastmod>2005-02-21T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4aanovel_cyclacel_compounds_granted_us_patent/</loc>
		<lastmod>2005-02-21T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed4a7spectrum_to_develop_chemoenhancing_agents/</loc>
		<lastmod>2005-02-21T09:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824b6scheringplough_completes_neogenesis_purchase/</loc>
		<lastmod>2005-02-21T09:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b4a5biogen_idecs_amevive_improves_psoriatic_arthritis/</loc>
		<lastmod>2005-02-21T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a490abbotts_humira_shines_again_in_psoriasis_study/</loc>
		<lastmod>2005-02-21T09:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d4b6genentechs_raptiva_shows_sustained_benefit_in_psoriasis/</loc>
		<lastmod>2005-02-21T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/26494spectrum_begins_glaxo_patent_challenge/</loc>
		<lastmod>2005-02-21T09:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4acdendreongenentech_combo_effective_in_prostate_cancer/</loc>
		<lastmod>2005-02-21T10:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3549amillennium_posts_promising_prostate_cancer_findings/</loc>
		<lastmod>2005-02-21T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4bdamgens_enbrel_improves_psoriasis_patients_wellbein/</loc>
		<lastmod>2005-02-21T10:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4a8cox2s_panel_relieves_merck_and_pfizers_pain_/</loc>
		<lastmod>2005-02-21T11:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c489novartis_purchases_create_global_generics_leade/</loc>
		<lastmod>2005-02-21T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c48fgsk_takes_steps_to_fight_hiv_drug_smugglin/</loc>
		<lastmod>2005-02-22T10:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0749abavarian_nordic_extends_rd_investme/</loc>
		<lastmod>2005-02-22T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/31483german_regulator_to_introduce_cox2_restriction/</loc>
		<lastmod>2005-02-22T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b749cadvitech_to_test_bowel_inflammation_agen/</loc>
		<lastmod>2005-02-22T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f549fnovartis_eczema_cream_effective_for_longterm_us/</loc>
		<lastmod>2005-02-22T10:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894a4ptc_cystic_fibrosis_drug_awarded_17_million_fundin/</loc>
		<lastmod>2005-02-22T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc49eresearchers_unlock_key_to_tarceva_iressa_resista/</loc>
		<lastmod>2005-02-22T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d4b0nicox_allergy_spray_brings_rapid_r/</loc>
		<lastmod>2005-02-22T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a54aanautilus_reaches_first_serono_deal_milestone/</loc>
		<lastmod>2005-02-22T10:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d49esantarus_launches_zegerid_40mg_in_the_u/</loc>
		<lastmod>2005-02-22T10:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a4b5pliva_and_mayne_enter_biogenerics_pac/</loc>
		<lastmod>2005-02-22T11:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/59495elan_cleared_to_market_prialt_in_e/</loc>
		<lastmod>2005-02-22T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce4b6uk_regulator_gets_militant_on_drug_ads_/</loc>
		<lastmod>2005-02-23T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9548abenitec_signs_nihfunded_aids_deal/</loc>
		<lastmod>2005-02-23T10:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b9492insmed_files_to_dismiss_somatokine_patent_suit/</loc>
		<lastmod>2005-02-23T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e74a2atherogenics_trial_amendment_gets_fda_o/</loc>
		<lastmod>2005-02-23T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf4b3scheringplough_to_copromote_child_respiratory_treatment/</loc>
		<lastmod>2005-02-23T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474b5targeted_genetics_up_on_hiv_vaccine_data/</loc>
		<lastmod>2005-02-23T10:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e8495ite_and_vaxgen_expand_bioshield_contract/</loc>
		<lastmod>2005-02-23T10:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f1485avax_up_on_lung_cancer_collaboration/</loc>
		<lastmod>2005-02-23T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c4a3mayne_launches_new_cancer_generic_formulatio/</loc>
		<lastmod>2005-02-23T10:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/00499teva_and_lundbeck_to_market_azilect_in_europe/</loc>
		<lastmod>2005-02-23T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b1490millenia_hope_begins_second_african_malaria_trial/</loc>
		<lastmod>2005-02-23T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/72480bayer_pleased_by_aleve_advisor/</loc>
		<lastmod>2005-02-23T10:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c4a2microsoft_to_assist_in_hiv_res/</loc>
		<lastmod>2005-02-24T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a4b5shire_adhd_drug_gets_teva_challenge/</loc>
		<lastmod>2005-02-24T09:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa483medco_announces_22_billion_accredo_purchase/</loc>
		<lastmod>2005-02-24T10:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec4a5antipsychotic_candidate_extends_memory_pipeline/</loc>
		<lastmod>2005-02-24T10:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/95489chemgenex_to_receive_vernalis_milestone_paymen/</loc>
		<lastmod>2005-02-24T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/924b3entremed_peptide_progressing_wel/</loc>
		<lastmod>2005-02-24T11:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b48eequitech_up_on_pain_drug_result/</loc>
		<lastmod>2005-02-24T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/94489astrazenecas_atacand_approved_for_heart_failur/</loc>
		<lastmod>2005-02-24T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/54480altachem_unveils_new_corporate_strateg/</loc>
		<lastmod>2005-02-24T11:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224a6gileads_truvada_gets_eu_o/</loc>
		<lastmod>2005-02-24T11:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b2485prolexys_licenses_novel_anticancer_compound/</loc>
		<lastmod>2005-02-24T11:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a249faustcancer_compound_shows_promise_in_prostate_c/</loc>
		<lastmod>2005-02-25T03:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae49dhuman_genome_sciences_colorectal_cancer_trial_progre/</loc>
		<lastmod>2005-02-25T04:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/57483third_dov_antidepressant_enters_c/</loc>
		<lastmod>2005-02-25T08:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed4adgenzyme_begins_phase_ii_cardio_/</loc>
		<lastmod>2005-02-25T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/134b6sanofiaventis_reports_pain_reliever_su/</loc>
		<lastmod>2005-02-25T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114b5alpharma_and_orchid_sign_generics_deal/</loc>
		<lastmod>2005-02-25T09:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c149bwyeth_wins_philadelphia_diet_drug_trial/</loc>
		<lastmod>2005-02-25T09:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/624afalteon_suspends_cardio_trial_enrollment/</loc>
		<lastmod>2005-02-25T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e44bdvicuron_antibiotic_granted_priority_revie/</loc>
		<lastmod>2005-02-25T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/194b4zonagen_drug_challenges_abbott_rival_in_tria/</loc>
		<lastmod>2005-02-25T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6498medicine_shoppe_to_stock_gelstat_migraine_dru/</loc>
		<lastmod>2005-02-25T09:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a4bdspectrum_submits_ninth_generic_filing/</loc>
		<lastmod>2005-02-25T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/464a9pfizer_to_buy/</loc>
		<lastmod>2005-02-25T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0549esankyo_and_daiichi_confirm_merger_/</loc>
		<lastmod>2005-02-25T11:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f487mylan_blood_pressure_drug_approval_delaye/</loc>
		<lastmod>2005-02-28T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44aememory_pharmaceuticals_compound_enters_clinic/</loc>
		<lastmod>2005-02-28T11:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b9498amgen_afterchemo_drug_shines_in_phase_iii/</loc>
		<lastmod>2005-02-28T11:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c948eroche_hepatitis_therapy_approved_for_hiv_patients/</loc>
		<lastmod>2005-02-28T11:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114a5mylan_and_king_end_merger_agreemen/</loc>
		<lastmod>2005-02-28T11:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d5498immuneregens_steroid_alternative_effective_in_asthma_tria/</loc>
		<lastmod>2005-02-28T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4a4intarcia_breast_cancer_therapy_enters_phas/</loc>
		<lastmod>2005-02-28T13:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4b7bcy_and_align_sign_licensing/</loc>
		<lastmod>2005-02-28T13:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd4aagenaera_eye_drug_performing_well_in_pha/</loc>
		<lastmod>2005-02-28T13:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c1493merck_drug_could_save_lives_from_prostate_c/</loc>
		<lastmod>2005-03-01T02:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad48aym_bio_reports_positive_data_from_child_cancer_/</loc>
		<lastmod>2005-03-01T09:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a4abactelion_hopeful_for_japanese_tracleer_l/</loc>
		<lastmod>2005-03-01T09:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e8496merseybio_selects_autonomy_to_support_biotechnology_ne/</loc>
		<lastmod>2005-03-01T10:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/274b8sosei_files_to_market_japanese_eligard/</loc>
		<lastmod>2005-03-01T10:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974bcschering_ag_and_cenix_sign_rd_advancement_deal/</loc>
		<lastmod>2005-03-01T10:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c49fpanacos_singledose_hiv_drug_effective_in_study/</loc>
		<lastmod>2005-03-01T10:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d49dosi_anticancer_agent_enters_clini/</loc>
		<lastmod>2005-03-01T10:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a4afbiogenelan_pull_tysabri_after_patient_death/</loc>
		<lastmod>2005-03-01T11:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/254b4medimmune_and_abbott_amend_antibodies/</loc>
		<lastmod>2005-03-01T11:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a48concolytics_cleared_to_start_brain_cancer_trial/</loc>
		<lastmod>2005-03-01T11:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/544a3axcan_launches_oncedaily_canasa__/</loc>
		<lastmod>2005-03-01T11:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2948cmedicure_reports_trial_successes_for_novel_antithromboti/</loc>
		<lastmod>2005-03-01T11:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d9487gw_speeds_up_plans_to_enter_us_marke/</loc>
		<lastmod>2005-03-01T11:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a48bvirxsys_novel_hiv_therapy_yields_exciting_re/</loc>
		<lastmod>2005-03-02T02:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb48felusys_files_to_begin_human_anthrax_st/</loc>
		<lastmod>2005-03-02T02:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a4b6sunesis_presents_promising_anticancer/</loc>
		<lastmod>2005-03-02T02:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f485medicinova_antianxiety_agent_enters_phase_i/</loc>
		<lastmod>2005-03-02T09:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/404b4nicox_compound_beats_aspirin_in_diabetes_tria/</loc>
		<lastmod>2005-03-02T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/66492takeda_and_3m_enter_development_and_marketing_pact/</loc>
		<lastmod>2005-03-02T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/02484uk_regulator_could_withdraw_alzheimers_drug/</loc>
		<lastmod>2005-03-02T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3849fmyriad_drug_to_enter_brain_cancer_tria/</loc>
		<lastmod>2005-03-02T09:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/494bcsamaritan_progressing_with_novel_hiv_dru/</loc>
		<lastmod>2005-03-02T09:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894a1valeant_launches_parkinsons_drug_in_europ/</loc>
		<lastmod>2005-03-02T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/964b3biovail_and_depomed_up_as_drug_approval_near/</loc>
		<lastmod>2005-03-02T09:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4481gloucester_begins_pivotal_lymphoma_tria/</loc>
		<lastmod>2005-03-02T09:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d4b6biofocus_and_lilly_ink_drug_target/</loc>
		<lastmod>2005-03-02T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc4b7immune_response_corp_plans_new_neurovax_stud/</loc>
		<lastmod>2005-03-02T12:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/42499roche_and_trimeris_report_benefits_of_fuzeon_comb/</loc>
		<lastmod>2005-03-02T12:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/23485diffusion_enters_new_cancer_therapies_allianc/</loc>
		<lastmod>2005-03-02T12:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884a7forests_lexapro_gets_second_nonapprovable_l/</loc>
		<lastmod>2005-03-03T02:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f549enew_river_adhd_drug_shows_promise_in_pha/</loc>
		<lastmod>2005-03-03T02:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e049amedicure_progressing_with_diabetic_hypertension_/</loc>
		<lastmod>2005-03-03T02:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/16491chiron_gains_as_flu_license_reinstate/</loc>
		<lastmod>2005-03-03T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/90493forbes_reducol_gets_further_approvals_/</loc>
		<lastmod>2005-03-03T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/76496mcrc_to_create_world_leader_in_cancer_researc/</loc>
		<lastmod>2005-03-03T10:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/414bfgeron_and_brc_form_telomerase_allianc/</loc>
		<lastmod>2005-03-03T10:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/56483schering_initiates_phase_ii_lung_cancer_stud/</loc>
		<lastmod>2005-03-03T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd4a7genvec_launches_phase_iib_heart_tria/</loc>
		<lastmod>2005-03-03T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b849bpacific_biometrics_signs_major_arthritis_cont/</loc>
		<lastmod>2005-03-03T11:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba4b9peregrine_antibody_effective_in_lung_c/</loc>
		<lastmod>2005-03-03T11:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee4afpfizer_and_sanofiaventis_looking_to_market_exuber/</loc>
		<lastmod>2005-03-03T11:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/704a0astrazeneca_up_on_crestor_relabeling_appro/</loc>
		<lastmod>2005-03-03T12:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad4b3andrx_to_divest_diabetes_and_cholesterol_drug/</loc>
		<lastmod>2005-03-03T12:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4b1gpc_acquires_axxima_asset/</loc>
		<lastmod>2005-03-03T12:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c749ecytogenix_herpes_cream_effective_prec/</loc>
		<lastmod>2005-03-04T03:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5548fceptor_licenses_myodur_t/</loc>
		<lastmod>2005-03-04T03:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b4b7corixa_and_lorantis_to_develop_hepatitis_b_va/</loc>
		<lastmod>2005-03-04T07:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0749ametabolex_diabetes_drug_welltolerated_in_ph/</loc>
		<lastmod>2005-03-04T07:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/45497supergen_begins_phase_ii_pancreatic_cancer_/</loc>
		<lastmod>2005-03-04T07:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64b5human_genome_sciences_lymphoma_trial_progre/</loc>
		<lastmod>2005-03-04T07:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a4b0pfizer_launches_freezer_pops_for_cough_relief_/</loc>
		<lastmod>2005-03-04T09:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4a6genzymes_thyrogen_gets_eu_o/</loc>
		<lastmod>2005-03-04T09:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b48dlabopharm_adds_russia_to_pain_drug_agreemen/</loc>
		<lastmod>2005-03-04T09:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb48fimpax_launches_oxycontin_generi/</loc>
		<lastmod>2005-03-04T09:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a4491cytokinetics_selects_heart_failure_candidat/</loc>
		<lastmod>2005-03-04T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974bdresearchers_say_some_hiv_patients_risk_exhausting_treatment_option/</loc>
		<lastmod>2005-03-04T10:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/25493flamel_ends_licensing_deal_with_biovail/</loc>
		<lastmod>2005-03-04T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/244a8nps_and_ventiv_launch_salesforce_for_amgen_drug/</loc>
		<lastmod>2005-03-04T10:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e488salix_and_altana_join_to_promote_antibioti/</loc>
		<lastmod>2005-03-04T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f4bcchemokine_thera_progressing_with_immune_recovery_drug_tria/</loc>
		<lastmod>2005-03-04T10:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f44b4leiner_health_launches_nutritional_supple/</loc>
		<lastmod>2005-03-04T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e49famplimed_initiates_phase_iii_cancer_combo_/</loc>
		<lastmod>2005-03-04T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d485biotagsk_lawsuit_boosted_by_uk_flu_stockpilin/</loc>
		<lastmod>2005-03-07T09:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7849ageron_reports_striking_cancer_vaccine_result/</loc>
		<lastmod>2005-03-07T09:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/00496scheringplough_to_launch_novel_allergy_dru/</loc>
		<lastmod>2005-03-07T09:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c4baneuren_and_metabolic_to_develop_nerve_repair_compound/</loc>
		<lastmod>2005-03-07T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4a4skyepharma_suffers_on_gsk_drug_seizures/</loc>
		<lastmod>2005-03-07T12:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d480glades_approved_to_market_generic_antifunga/</loc>
		<lastmod>2005-03-07T12:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644bechiron_and_sourcecf_reach_settlement_agreemen/</loc>
		<lastmod>2005-03-07T12:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4adastrazenecas_seroquel_shows_safety_in_geriatric_dementi/</loc>
		<lastmod>2005-03-07T12:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b848fuk_to_get_gbp1_billion_biotech_funding_by_2008/</loc>
		<lastmod>2005-03-07T12:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a495research_highlights_significant_aspirin_and_plavix_resistance/</loc>
		<lastmod>2005-03-07T12:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/94491glycogenesys_to_close_cancer_funding_deal/</loc>
		<lastmod>2005-03-08T03:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/13496celgene_reports_phase_iii_revlimid_succes/</loc>
		<lastmod>2005-03-08T09:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8649aevotec_acquires_ens_gets_e47_million_fundin/</loc>
		<lastmod>2005-03-08T09:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/97480lynx_and_solexa_ltd_complete_merge/</loc>
		<lastmod>2005-03-08T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/21488adventrx_cancer_drug_enhancer_effective_in_phase_i/</loc>
		<lastmod>2005-03-08T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e34b8medarexbms_antibody_shows_tumor_response_in_tria/</loc>
		<lastmod>2005-03-08T11:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/24499bioalliance_results_show_hope_for_hiv_drug_resistanc/</loc>
		<lastmod>2005-03-08T11:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314b0cell_thera_nosedives_on_lung_cancer_trial_failur/</loc>
		<lastmod>2005-03-08T11:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/904bajj_and_gns_sign_cancer_drug_development_dea/</loc>
		<lastmod>2005-03-08T11:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224a4lillys_cymbalta_shows_benefit_in_elderly_patient/</loc>
		<lastmod>2005-03-08T11:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb4aaaspirin_reduces_stroke_risk_study_shows/</loc>
		<lastmod>2005-03-08T12:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e488bavarian_nordics_smallpox_vaccine_top_for_safet/</loc>
		<lastmod>2005-03-08T12:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a84a9bmsotsukas_abilify_gets_new_indication_approval/</loc>
		<lastmod>2005-03-08T12:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/784afteva_and_eisais_agilect_shows_longterm_benefit/</loc>
		<lastmod>2005-03-08T12:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3949arenovis_drug_fails_phase_ii_pain_/</loc>
		<lastmod>2005-03-09T11:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae484marshall_edwards_speeds_up_pivotal_cancer_/</loc>
		<lastmod>2005-03-09T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334baunited_thera_hypertension_drug_gets_fren/</loc>
		<lastmod>2005-03-09T11:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b4afbayer_and_onyx_begin_phase_iii_liver_cancer_/</loc>
		<lastmod>2005-03-09T11:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f489cotherix_hypertension_drug_fares_well_in_combo_/</loc>
		<lastmod>2005-03-09T12:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4b2dutch_to_offer_first_affordable_hiv_insura/</loc>
		<lastmod>2005-03-09T12:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2749ctetrabenazine_may_be_suitable_for_patients_with_history_of_depre/</loc>
		<lastmod>2005-03-09T12:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb49fboehringer_drug_gives_rapid_relief_in_/</loc>
		<lastmod>2005-03-09T12:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8048dcorautus_gene_therapy_shows_continued_angina_r/</loc>
		<lastmod>2005-03-09T12:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/98480pfizer_down_on_lipitor_trial/</loc>
		<lastmod>2005-03-09T12:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/70493positive_results_stop_landmark_pfizer_heart_/</loc>
		<lastmod>2005-03-09T12:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/38492decode_initiates_phase_i_atherosclerosis_/</loc>
		<lastmod>2005-03-09T12:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e94bddiversa_gets_48_million_biodefense_cont/</loc>
		<lastmod>2005-03-09T12:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c4a0mixed_results_for_sanofiaventis_diet/</loc>
		<lastmod>2005-03-09T13:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e249cstridafunded_research_makes_cancer_target_breakth/</loc>
		<lastmod>2005-03-09T13:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a1489labopharm_seeks_mexican_pain_dr/</loc>
		<lastmod>2005-03-09T13:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e4491allon_compounds_show_potential_in_eye_di/</loc>
		<lastmod>2005-03-10T06:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b49fpredix_anxiety_drug_enters_pha/</loc>
		<lastmod>2005-03-10T06:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd4abceptor_files_to_strengthen_neuro_pa/</loc>
		<lastmod>2005-03-10T06:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/944b3applied_bio_and_fda_to_study_diabetes_drug_toxicit/</loc>
		<lastmod>2005-03-10T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d4bdlorus_cancer_therapy_induces_immune_respons/</loc>
		<lastmod>2005-03-10T11:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/08482tanox_completes_hiv_trial_enrollmen/</loc>
		<lastmod>2005-03-10T11:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a54a2biota_and_aerogen_sign_flu_drug_dea/</loc>
		<lastmod>2005-03-10T11:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b4bemajority_abandon_cox2s_spinehealth_poll_show/</loc>
		<lastmod>2005-03-10T11:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0749dsanofi_pasteur_to_launch_preservativefree_child_flu_ja/</loc>
		<lastmod>2005-03-10T12:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca496jj_to_acquire_transfor/</loc>
		<lastmod>2005-03-10T12:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/57497avanir_acquires_additional_neurodex_right/</loc>
		<lastmod>2005-03-10T12:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b2489immune_response_corps_remune_fights_hiv_in_phase_i/</loc>
		<lastmod>2005-03-10T12:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/754b2pharming_cleared_for_canadian_edema_trial/</loc>
		<lastmod>2005-03-10T12:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d48emaxim_rises_on_leukemia_drug_designatio/</loc>
		<lastmod>2005-03-10T12:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa499kos_files_to_block_barr_generic/</loc>
		<lastmod>2005-03-10T12:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a849cinyx_and_novadel_expand_partne/</loc>
		<lastmod>2005-03-10T13:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a94b3perlegen_study_could_uncover_new_arthritis_treat/</loc>
		<lastmod>2005-03-11T06:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4b1sanofi_pasteur_delivers_pandemic_flu_vaccine_t/</loc>
		<lastmod>2005-03-11T06:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bd4b3millennium_initiates_velcade_retreatment_/</loc>
		<lastmod>2005-03-11T06:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384b9vical_gets_31_million_nih_vaccine_/</loc>
		<lastmod>2005-03-11T06:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47498biotech_holdings_boosted_by_sucanon_marketing_approv/</loc>
		<lastmod>2005-03-11T06:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa4b6equitech_pain_drug_beats_jj_rival_in_phase_i/</loc>
		<lastmod>2005-03-11T09:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e9493vitex_and_panacos_shareholders_approve_merger/</loc>
		<lastmod>2005-03-11T09:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/14484journal_says_opioids_viable_cox2s_alternative/</loc>
		<lastmod>2005-03-11T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f7483fda_warns_on_novartis_fujisawa_skin_drugs/</loc>
		<lastmod>2005-03-11T09:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/29498fuzeon_sales_growth_improves_trimeris_earning/</loc>
		<lastmod>2005-03-11T09:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/05488health_advocates_push_for_fda_advisory_refor/</loc>
		<lastmod>2005-03-11T10:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e4b7more_positive_results_for_tevas_agilect_/</loc>
		<lastmod>2005-03-11T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/564b9biogen_general_counsel_re/</loc>
		<lastmod>2005-03-11T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d64aedermatology_academy_defends_novartis_fujisawa_/</loc>
		<lastmod>2005-03-11T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/364abxoma_soars_on_bioterrorism_con/</loc>
		<lastmod>2005-03-11T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/13481research_shows_soap_and_water_best_for_hand_hy/</loc>
		<lastmod>2005-03-11T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d8486adherex_and_nci_sign_exherin_development/</loc>
		<lastmod>2005-03-14T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a4b7savient_ends_hiv_pain_/</loc>
		<lastmod>2005-03-14T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b496sanofiaventis_sues_novo/</loc>
		<lastmod>2005-03-14T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824a1fda_panel_backs_bristolmyers_hepatitis/</loc>
		<lastmod>2005-03-14T09:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3f4afaxonyx_alzheimers_trial_continues_at_higher/</loc>
		<lastmod>2005-03-14T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/284a4researchers_discovery_may_lead_to_better_antifungal_/</loc>
		<lastmod>2005-03-14T10:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b481sepracor_inhaler_gets_f/</loc>
		<lastmod>2005-03-14T10:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/70489research_shows_growth_hormone_effective_in_metabolic_diso/</loc>
		<lastmod>2005-03-14T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/72490rna_interference_offers_neurological_promise_research_/</loc>
		<lastmod>2005-03-14T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c49caegate_pilot_shows_rfid_ben/</loc>
		<lastmod>2005-03-14T10:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4a4endo_licenses_antiinflammatory_/</loc>
		<lastmod>2005-03-14T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/74496durect_licenses_pain_patch_to/</loc>
		<lastmod>2005-03-14T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4a7app_abraxane_suit_droppe/</loc>
		<lastmod>2005-03-15T10:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc49ela_jolla_plummets_as_riquent_talks_continue/</loc>
		<lastmod>2005-03-15T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c4b7biobalance_selects_gastro_drug_maker/</loc>
		<lastmod>2005-03-15T10:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd48aprana_moves_second_alzheimers_compound_into_clinic/</loc>
		<lastmod>2005-03-15T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b548dgenerex_orallyn_matches_fastacting_insuli/</loc>
		<lastmod>2005-03-15T10:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa4b2repligen_signs_bipolar_drug_funding_deal/</loc>
		<lastmod>2005-03-15T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/15481gammacan_commences_phase_ii_cancer_tria/</loc>
		<lastmod>2005-03-15T10:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5149fgenentech_and_roches_avastin_shows_further_survival_benefi/</loc>
		<lastmod>2005-03-15T10:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/934a7fda_rejects_petition_to_withdraw_astrazenecas_cresto/</loc>
		<lastmod>2005-03-15T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/96485wyeth_trial_to_use_virtualscopics_service/</loc>
		<lastmod>2005-03-15T10:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4b0critical_thera_initiates_zyflo_bridge_stud/</loc>
		<lastmod>2005-03-15T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c649bpharmacyclics_progressing_with_phase_iii_lung_cancer_/</loc>
		<lastmod>2005-03-16T02:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e948cactelionmerck_alliance_achieves_second_milest/</loc>
		<lastmod>2005-03-16T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334a5nicox_drug_could_improve_asthma_treatm/</loc>
		<lastmod>2005-03-16T10:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4a0seattle_genetics_up_on_genentech_milest/</loc>
		<lastmod>2005-03-16T10:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/53484quatrx_licenses_novel_lipid_d/</loc>
		<lastmod>2005-03-16T10:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/69483amarin_boosted_by_depression_trial_d/</loc>
		<lastmod>2005-03-16T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444b0genta_leukemia_drug_gets_orphan_sta/</loc>
		<lastmod>2005-03-16T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/714b7viacell_soars_on_diabetes_new/</loc>
		<lastmod>2005-03-16T10:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8449aid_biomedical_to_pursue_accelerated_approval_for_flu/</loc>
		<lastmod>2005-03-16T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f4bdthird_sinovac_jab_gets_chinese/</loc>
		<lastmod>2005-03-16T11:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/36481fda_panel_favors_gsk_and_sanofiaventis_vaccin/</loc>
		<lastmod>2005-03-16T11:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4beadvanced_biotherapy_optimistic_about_aids_tr/</loc>
		<lastmod>2005-03-16T11:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea4b9icagen_up_on_yamanouchi_milestone_paym/</loc>
		<lastmod>2005-03-16T11:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c348aepimmune_and_idm_to_me/</loc>
		<lastmod>2005-03-17T11:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1648fcyclacel_to_speed_up_altana_drug_developm/</loc>
		<lastmod>2005-03-17T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a48bms_debacle_continues_with_gsk_biogen_/</loc>
		<lastmod>2005-03-17T11:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/274a2weill_cornell_and_clinique_establish_skin_c/</loc>
		<lastmod>2005-03-17T11:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/98499sankyo_stops_trials_of_metabasis_diabetes_d/</loc>
		<lastmod>2005-03-17T12:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/274aachemokine_compound_shines_in_bone_cancer_stud/</loc>
		<lastmod>2005-03-17T12:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9149eoncogenex_and_isis_expand_oncology_partners/</loc>
		<lastmod>2005-03-17T12:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c4b2anormed_begins_trial_of_new_hiv_drug/</loc>
		<lastmod>2005-03-17T12:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4bfscheringploughs_temodar_gets_fda/</loc>
		<lastmod>2005-03-17T12:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/02485amylins_symlin_gets_fda_ok_in_dia/</loc>
		<lastmod>2005-03-18T03:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe4bafujisawa_antifungal_gets_f/</loc>
		<lastmod>2005-03-18T03:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c4b6predix_to_get_125_million_for_cystic_fibrosis_res/</loc>
		<lastmod>2005-03-18T03:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b048eserono_makes_milestone_ms_discover/</loc>
		<lastmod>2005-03-18T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec4adimmunogen_gets_milestone_payment_as_sanofiaventis_starts_tr/</loc>
		<lastmod>2005-03-18T09:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/704b7insmed_and_ucsf_ink_prostate_cancer_d/</loc>
		<lastmod>2005-03-18T09:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b8490enzon_terminates_inex_agreeme/</loc>
		<lastmod>2005-03-18T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4b6sanofi_pasteur_seeks_to_broaden_menactra_age_gr/</loc>
		<lastmod>2005-03-18T10:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e64b2viragen_antibody_enhances_biogengenentech_d/</loc>
		<lastmod>2005-03-18T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b4b0introgen_compound_shows_activity_in_advanced_can/</loc>
		<lastmod>2005-03-18T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/48491austcancer_progressing_with_phase_iib_pentrys_tria/</loc>
		<lastmod>2005-03-18T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/134a2accenture_and_adobe_develop_enterprise_portal_for/</loc>
		<lastmod>2005-03-18T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064a0stanford_researchers_make_skin_cancer_breakth/</loc>
		<lastmod>2005-03-18T11:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/694ababgenix_reports_progress_in_amgen_cancer_tria/</loc>
		<lastmod>2005-03-21T10:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d484palatin_cheered_by_viagra_enhancer_trial/</loc>
		<lastmod>2005-03-21T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f2495torreypines_signs_second_eisai_discovery_deal/</loc>
		<lastmod>2005-03-21T11:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a491neopharm_anticancer_compound_beats_lilly_rival_in_mice/</loc>
		<lastmod>2005-03-21T11:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b4bacrucell_up_on_nih_ebola_license/</loc>
		<lastmod>2005-03-21T11:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1648dshire_and_novartis_dip_on_adhd_drug_risks__/</loc>
		<lastmod>2005-03-21T11:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c48cdynavax_and_ucb_end_allergy_progra/</loc>
		<lastmod>2005-03-21T11:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/34492swri_gets_16_million_nanocapsules_contrac/</loc>
		<lastmod>2005-03-21T11:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4aboscient_steps_up_antibiotic_sales_effort/</loc>
		<lastmod>2005-03-21T11:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a4a8alnylam_up_on_in_vivo_infection_data/</loc>
		<lastmod>2005-03-21T11:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/624b4global_forum_seeks_treaty_to_fight_counterfeitin/</loc>
		<lastmod>2005-03-21T11:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6048dschering_ag_and_novartis_cancer_drug_disapp/</loc>
		<lastmod>2005-03-22T02:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524b9bayeronyx_drug_delays_kidney_cancer_progression/</loc>
		<lastmod>2005-03-22T09:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e493altana_asthma_drug_comparable_to_rival/</loc>
		<lastmod>2005-03-22T09:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/794a5bioenvision_drug_performing_well_in_leukemia/</loc>
		<lastmod>2005-03-22T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/684a8stressgen_treatment_outshines_expectations_in_phase_i/</loc>
		<lastmod>2005-03-22T11:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d48cforest_launches_novel_shortterm_pain_drug/</loc>
		<lastmod>2005-03-22T11:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d2497astrazeneca_study_shows_early_budesonide_benefit/</loc>
		<lastmod>2005-03-22T11:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc4a5banner_soflet_gelcaps_aid_anticounterfeiting_measur/</loc>
		<lastmod>2005-03-22T11:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/80488biolex_and_centocor_sign_protein_manufacturing_dea/</loc>
		<lastmod>2005-03-22T11:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b149bgsk_and_tb_alliance_launch_drug_discovery_program/</loc>
		<lastmod>2005-03-22T11:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b48bmerix_sues_gsk_over_cold_sore_drug_ad/</loc>
		<lastmod>2005-03-22T11:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba4a6st_jude_research_suggests_new_lymphoma_drug_t/</loc>
		<lastmod>2005-03-22T13:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e2480roche_initiates_trial_in_posttransplant_hepa/</loc>
		<lastmod>2005-03-22T13:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a495abbott_permitted_to_appeal_cat_suit_r/</loc>
		<lastmod>2005-03-22T13:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/93499merck_vaccines_eliminate_us_rubella_health_t/</loc>
		<lastmod>2005-03-22T13:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/054a4osi_announces_first_euro_ok_for_tarceva/</loc>
		<lastmod>2005-03-23T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff498gilead_and_japan_tobacco_pen_hiv_licensing_dea/</loc>
		<lastmod>2005-03-23T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94acms_therapy_could_fight_asthma_researchers_clai/</loc>
		<lastmod>2005-03-23T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b9489propharmaceuticals_davant_enhances_avastin_comb/</loc>
		<lastmod>2005-03-23T10:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7248ecotherix_hypertension_drug_commercially_availabl/</loc>
		<lastmod>2005-03-23T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1948bgsk_and_medco_join_for_medicare_prescription_s/</loc>
		<lastmod>2005-03-23T10:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b4aesaegis_lead_compound_enters_phase_ii_in/</loc>
		<lastmod>2005-03-23T10:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a5485cytrx_progressing_with_phase_i_hiv_/</loc>
		<lastmod>2005-03-23T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a48bmetabolex_drug_could_advance_diabetes_trea/</loc>
		<lastmod>2005-03-23T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0549cnanogen_and_pathway_to_help_personalize_drug_prescr/</loc>
		<lastmod>2005-03-23T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4a6bms_extends_aids_programs_assistance/</loc>
		<lastmod>2005-03-23T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a74b8positive_results_for_altana_and_sanofiaventis_alvesc/</loc>
		<lastmod>2005-03-23T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334bdfda_guidelines_to_help_personalized_drug_development/</loc>
		<lastmod>2005-03-23T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264b1scheringplough_celebrates_claritin_switch_su/</loc>
		<lastmod>2005-03-24T03:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/32487aeternas_impavido_gets_colombian_goahead/</loc>
		<lastmod>2005-03-24T10:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c49esavient_and_ferring_to_comarket_nuflexx/</loc>
		<lastmod>2005-03-24T10:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/59491pharmacopeia_and_cv_thera_sign_cardio_discovery_dea/</loc>
		<lastmod>2005-03-24T10:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/00490protein_design_labs_nuvion_development_delaye/</loc>
		<lastmod>2005-03-24T10:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c14adprocyon_reports_encouraging_results_for_hiv_prodru/</loc>
		<lastmod>2005-03-24T10:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994abcuris_achieves_wyeth_collaboration_mile/</loc>
		<lastmod>2005-03-24T10:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a497ivax_launches_generic_neurontin_cap/</loc>
		<lastmod>2005-03-24T10:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/904a3biotech_medics_acquires_fhj_pa/</loc>
		<lastmod>2005-03-24T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f4b7ranbaxy_adds_to_hiv_fi/</loc>
		<lastmod>2005-03-24T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f3495pharmagap_progressing_with_cancer_compound_/</loc>
		<lastmod>2005-03-24T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e4a7xcyte_cuts_24_of_workforce_following_r/</loc>
		<lastmod>2005-03-24T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6349eicos_dips_on_lung_trial_fa/</loc>
		<lastmod>2005-03-24T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e483nih_initiates_avian_flu_vaccine_tria/</loc>
		<lastmod>2005-03-24T12:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b495kensey_nash_gets_fda_clearance_for_its_triactiv_embolic_protection_s/</loc>
		<lastmod>2005-03-24T13:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e94a8dr_reddys_and_icici_sign_56_million_generics_dea/</loc>
		<lastmod>2005-03-29T09:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5496ligand_plummets_on_lung_cancer_trial_failur/</loc>
		<lastmod>2005-03-29T09:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/af482tanox_acquires_sunol_antibodie/</loc>
		<lastmod>2005-03-29T09:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f4b3alfacells_onconase_granted_orphan_status_in_australi/</loc>
		<lastmod>2005-03-29T09:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a348fmedicines_company_halts_heart_drug_tria/</loc>
		<lastmod>2005-03-29T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334b6parallele_enters_collaboration_for_eye_disease_researc/</loc>
		<lastmod>2005-03-29T09:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c4b0fda_accepts_morphotek_cancer_filin/</loc>
		<lastmod>2005-03-29T09:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4948ebaxter_to_market_cangene_treatment_in_the_u/</loc>
		<lastmod>2005-03-29T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a49btheravance_antibiotic_fast_tracked_by_fd/</loc>
		<lastmod>2005-03-29T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994afmillenniums_velcade_gets_full_fda_approva/</loc>
		<lastmod>2005-03-29T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea4a6scolr_pharma_reports_positive_decongestant_dat/</loc>
		<lastmod>2005-03-29T10:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e2497allergan_and_sanwa_sign_eye_drug_dea/</loc>
		<lastmod>2005-03-29T10:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e496genmab_completes_accrual_in_leukemia_/</loc>
		<lastmod>2005-03-30T09:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/234a0aeolus_optimistic_about_lou_gehrigs/</loc>
		<lastmod>2005-03-30T09:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/26480viventia_posts_promising_cancer/</loc>
		<lastmod>2005-03-30T09:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0948elannetts_generic_brethine_gets_fda_ok/</loc>
		<lastmod>2005-03-30T10:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/904aealnylam_and_dowpharma_sign_manufacturing_dea/</loc>
		<lastmod>2005-03-30T10:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd48cpfizer_contraceptive_approved_for_pain_relie/</loc>
		<lastmod>2005-03-30T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4bctorreypines_identifies_promising_alzheimers_compound/</loc>
		<lastmod>2005-03-30T11:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a24b6saegislilly_compound_proves_safe_in_phase_/</loc>
		<lastmod>2005-03-30T11:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/21499chroma_and_dpi_enter_cancer_discovery_pact/</loc>
		<lastmod>2005-03-30T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c54a5immune_response_hiv_drug_picked_for_nih_/</loc>
		<lastmod>2005-03-31T02:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/71494pfizer_ranbaxy_continue_heart_drug_ba/</loc>
		<lastmod>2005-03-31T02:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b499bms_up_on_us_hepatit/</loc>
		<lastmod>2005-03-31T03:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4b1lab_initiates_phase_ii_cancer_pain_/</loc>
		<lastmod>2005-03-31T03:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d48aadvancis_completes_enrollment_in_antiinfective_/</loc>
		<lastmod>2005-03-31T03:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4benicox_gets_second_pfizer_payment/</loc>
		<lastmod>2005-03-31T09:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a4493la_jolla_to_axe_40_of_workforc/</loc>
		<lastmod>2005-03-31T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f04abdaiichi_and_cyntellect_partner_for_drug_discovery/</loc>
		<lastmod>2005-03-31T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d74b6maxygen_boosted_by_roche_milestone_/</loc>
		<lastmod>2005-03-31T10:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc48dcorautus_up_on_favorable_trial_review/</loc>
		<lastmod>2005-03-31T10:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea498barr_and_kos_enter_niaspan_settlement_discussion/</loc>
		<lastmod>2005-03-31T10:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314bdaeras_and_ssi_sign_tb_vaccine/</loc>
		<lastmod>2005-03-31T11:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/544a6pfizers_geodon_found_effective_in_psychiatric_emergenc/</loc>
		<lastmod>2005-03-31T12:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/43490biovail_forced_to_delay_launch_of_pain_d/</loc>
		<lastmod>2005-03-31T12:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/12484scientists_seek_answers_on_what_activates_deadly_anthrax_spo/</loc>
		<lastmod>2005-03-31T12:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c4a8id_biomedical_completes_us_fluviral_trial_enrollmen/</loc>
		<lastmod>2005-04-01T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/514aafda_deals_forest_lexapro_approval_blo/</loc>
		<lastmod>2005-04-01T07:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/42486serono_signs_inhaleable_ms_therapy_deal/</loc>
		<lastmod>2005-04-01T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224bffujisawa_and_roche_to_copromote_mycamin/</loc>
		<lastmod>2005-04-01T07:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4a9immunogen_seeks_approval_for_anticancer_trials/</loc>
		<lastmod>2005-04-01T07:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824a4heavy_metal_band_to_fight_anthrax_vaccine/</loc>
		<lastmod>2005-04-01T07:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d44abinyx_completes_aventis_puerto_rico_bu/</loc>
		<lastmod>2005-04-01T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/83498ptc_cystic_fibrosis_drug_fast_tracked/</loc>
		<lastmod>2005-04-01T10:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/374bcdermatrends_develops_groundbreaking_nsaid/</loc>
		<lastmod>2005-04-01T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae490fda_approves_scheringploughs_as/</loc>
		<lastmod>2005-04-01T12:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24a5sanofi_pasteurs_new_polio_vaccine_to_help_global_eradic/</loc>
		<lastmod>2005-04-01T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc494cytos_and_medarex_expand_collabor/</loc>
		<lastmod>2005-04-04T08:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0448atheraquest_pain_drug_performing/</loc>
		<lastmod>2005-04-04T08:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/00484sepracor_to_launch_insomnia/</loc>
		<lastmod>2005-04-04T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b48fmigenix_gets_9_million_for_antibacteria/</loc>
		<lastmod>2005-04-04T08:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114a7critical_thera_seeks_asthma_drug_o/</loc>
		<lastmod>2005-04-04T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b84begenentech_files_for_human_skin_cancer_trial/</loc>
		<lastmod>2005-04-04T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54a8anormed_files_to_test_cancer_drug_in_heart_trials_/</loc>
		<lastmod>2005-04-04T10:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf481fda_approves_astrazenecas_intravenous_nexiu/</loc>
		<lastmod>2005-04-04T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/604a0callisto_gets_funding_for_bioweapon_defense_agent/</loc>
		<lastmod>2005-04-04T10:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b5496antisoma_to_list_shares_in_u/</loc>
		<lastmod>2005-04-04T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee496ranbaxy_gets_macrobid_generic_ok_settles_uk_sui/</loc>
		<lastmod>2005-04-04T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb491sanofi_pasteur_flu_jab_production_gets_hhs_boos/</loc>
		<lastmod>2005-04-04T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/174a4yamanouchi_and_fujisawa_form_astellas_pharm/</loc>
		<lastmod>2005-04-04T10:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/494a4astrazenecas_zoladex_extends_survival_in_prostate_cance/</loc>
		<lastmod>2005-04-04T10:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064a9pfizers_viagra_could_treat_pregnancy_complication/</loc>
		<lastmod>2005-04-04T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1149edutch_researchers_uncover_new_arthritis_drugs_scare/</loc>
		<lastmod>2005-04-04T12:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce483bayer_completes_plasma_business_sal/</loc>
		<lastmod>2005-04-04T12:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa48bgsk_ceo_to_answer_further_questions_in_aids_drug/</loc>
		<lastmod>2005-04-05T11:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f4b6pharmamar_and_jj_move_cancer_drug_into_phas/</loc>
		<lastmod>2005-04-05T11:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44a8nuvelo_and_kirin_to_develop_inflammation_compoun/</loc>
		<lastmod>2005-04-05T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4acamerican_bioscience_initiates_abraxaneherceptin_combo_stud/</loc>
		<lastmod>2005-04-05T11:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5482acorda_launches_spasticity_capsule/</loc>
		<lastmod>2005-04-05T11:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d548aperegrine_compounds_to_be_tested_for_antiviral_potentia/</loc>
		<lastmod>2005-04-05T11:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a491biovail_receives_courts_favor_in_tiazac_actio/</loc>
		<lastmod>2005-04-05T11:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2149acuris_up_on_second_major_genentech_pac/</loc>
		<lastmod>2005-04-05T11:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/854b6ligand_gets_milestone_on_tap_filin/</loc>
		<lastmod>2005-04-05T11:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e480holliseden_secondgen_compounds_show_disease_benefi/</loc>
		<lastmod>2005-04-05T11:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d487gileadjapan_tobacco_deal_gets_early_clea/</loc>
		<lastmod>2005-04-06T02:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/564b9janus_submits_filing_for_shingles_drug_t/</loc>
		<lastmod>2005-04-06T02:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e4a9uk_government_probe_finds_major_failings_in_drug_regul/</loc>
		<lastmod>2005-04-06T03:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e34a5lorus_signs_cancer_pact_with_sumitomo_and_koke/</loc>
		<lastmod>2005-04-06T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a495cotherix_and_quadrant_to_develop_secondgen_ventavis/</loc>
		<lastmod>2005-04-06T10:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4948fziopharm_cancer_compound_gets_fda_application_approval_/</loc>
		<lastmod>2005-04-06T10:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/32490nastech_and_mayo_clinic_join_for_arthritis_stud/</loc>
		<lastmod>2005-04-06T10:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214b7roche_and_kosan_phase_ii_breast_cancer_trial_to_proceed/</loc>
		<lastmod>2005-04-06T10:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b848eglycogenesys_initiates_phase_iii_blood_cancer_trial/</loc>
		<lastmod>2005-04-06T10:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/544a7avigen_to_stop_funding_gene_therapy_program/</loc>
		<lastmod>2005-04-06T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c482entremeds_panzem_shows_antiarthritic_activity_in_preclinic_/</loc>
		<lastmod>2005-04-06T10:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c94b3introgen_compound_may_enable_new_approach_to_cancer/</loc>
		<lastmod>2005-04-06T11:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94bfpfizer_expects_performance_rebound_in_2006/</loc>
		<lastmod>2005-04-06T11:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d49buk_scientists_make_key_allergy_control_finding/</loc>
		<lastmod>2005-04-06T11:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b49eprotox_gets_rights_to_market_lung_cancer_th/</loc>
		<lastmod>2005-04-07T02:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4a0cell_therapeutics_progressing_with_phase_iii_leukemia_/</loc>
		<lastmod>2005-04-07T02:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff4a0alkermes_up_on_alcoholism_drug_su/</loc>
		<lastmod>2005-04-07T02:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c3485serono_trials_halted_cancervax_plu/</loc>
		<lastmod>2005-04-07T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f148bhuman_genome_sciences_up_on_arthritis_trial_su/</loc>
		<lastmod>2005-04-07T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d34b7cancer_drug_found_to_help_arthritis_pat/</loc>
		<lastmod>2005-04-07T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/65480good_early_results_for_novenshire_adhd_/</loc>
		<lastmod>2005-04-07T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/62499incytes_novel_oral_cancer_compound_enters_c/</loc>
		<lastmod>2005-04-07T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214bdargos_begins_personalized_melanoma_vaccine_/</loc>
		<lastmod>2005-04-07T11:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e44a7oscient_and_lg_amend_factive_agre/</loc>
		<lastmod>2005-04-07T11:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e4a4amersin_subsidiary_gets_36_million_con/</loc>
		<lastmod>2005-04-07T11:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d4a8indevus_gets_uk_government_funding_for_hiv_/</loc>
		<lastmod>2005-04-07T11:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/574a7texas_and_canadian_pharmacists_fight_internet_drugs_import/</loc>
		<lastmod>2005-04-07T11:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e0497ecopia_gets_first_patent_for_its_discov/</loc>
		<lastmod>2005-04-07T11:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee483lilly_and_novartis_antipsychotics_keep_patients_on_treatment_l/</loc>
		<lastmod>2005-04-07T11:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d498plexxikon_and_invitrogen_sign_broad_screening/</loc>
		<lastmod>2005-04-07T11:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d84a6merck_vaccine_reduces_infection_in_pha/</loc>
		<lastmod>2005-04-08T06:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd4bepfizer_pulls_bextra_in_us_and_e/</loc>
		<lastmod>2005-04-08T06:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b34a7arakis_arthritis_drug_proves_safe_in_pha/</loc>
		<lastmod>2005-04-08T06:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/134b3sepracor_launches_lunesta_/</loc>
		<lastmod>2005-04-08T06:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e4bbbiogen_idec_up_on_psoriasis_study_tr/</loc>
		<lastmod>2005-04-08T06:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c4a5wyeth_buys_additional_wyeth_kk_equity_from_t/</loc>
		<lastmod>2005-04-08T08:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9148echemgenex_launches_phase_ii_gleevec_combo_/</loc>
		<lastmod>2005-04-08T10:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e48axenoport_prodrug_relieves_pain_in_phase_ii_/</loc>
		<lastmod>2005-04-08T10:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/724afallergans_botox_shows_promise_in_chronic_mig/</loc>
		<lastmod>2005-04-08T10:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a84bcgenomed_offers_treatment_for_sm/</loc>
		<lastmod>2005-04-08T10:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b4b4wex_gets_codeveloper_payment_for_pain/</loc>
		<lastmod>2005-04-08T11:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c4aacardiome_drug_improves_cardiac_fun/</loc>
		<lastmod>2005-04-08T11:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e4adbasilea_and_jj_initiate_phase_iii_antibiotic_t/</loc>
		<lastmod>2005-04-11T09:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d8487celgene_files_to_market_blood_disorders_trea/</loc>
		<lastmod>2005-04-11T09:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474b5innovate_acquires_rights_to_prostate_cancer_/</loc>
		<lastmod>2005-04-11T09:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a3494fda_approves_mercks_vitaminenhanced_fo/</loc>
		<lastmod>2005-04-11T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/694acenzo_unit_allowed_patent_interference_a/</loc>
		<lastmod>2005-04-11T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f44aamedicure_issued_second_stroke_treatment_p/</loc>
		<lastmod>2005-04-11T11:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/81495yale_researchers_make_heart_kidney_breakth/</loc>
		<lastmod>2005-04-11T11:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4b5supersentitivity_study_points_to_improved_antipsych/</loc>
		<lastmod>2005-04-11T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/084a7wake_forest_study_could_lead_to_new_cholesterol_/</loc>
		<lastmod>2005-04-11T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54a3institute_of_medicine_supports_1997_aids_study_fin/</loc>
		<lastmod>2005-04-11T11:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b54baalternative_medicine_popular_with_older_adults_study_/</loc>
		<lastmod>2005-04-11T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/73482swedish_scientists_make_multidisease_gene_breakth/</loc>
		<lastmod>2005-04-11T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6481few_women_willing_to_use_astrazenecas_nolvadex_study_/</loc>
		<lastmod>2005-04-11T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/854bbqlt_and_vasogenix_to_develop_heart_failure_trea/</loc>
		<lastmod>2005-04-11T11:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994aekaro_bio_dips_as_merck_halts_t/</loc>
		<lastmod>2005-04-12T07:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734a2actelion_cleared_to_market_tracleer_in_/</loc>
		<lastmod>2005-04-12T07:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1548aanticancer_combination_shows_promise_in_pha/</loc>
		<lastmod>2005-04-12T07:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4a1fda_delays_new_sanofiaventis_sleep/</loc>
		<lastmod>2005-04-12T08:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/924basepracors_lunesta_shines_in_second_longterm_/</loc>
		<lastmod>2005-04-12T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/41485prana_ditches_alzheimers_drug_pr/</loc>
		<lastmod>2005-04-12T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b4a0ucla_study_points_to_cox2s_alterna/</loc>
		<lastmod>2005-04-12T08:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d1486reliant_and_novartis_extend_heart_drug_promotion/</loc>
		<lastmod>2005-04-12T08:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c8489diobex_gets_worldwide_cortisol_inhibitor_r/</loc>
		<lastmod>2005-04-12T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64a5gsk_and_roche_to_promote_xenical_diabetes_be/</loc>
		<lastmod>2005-04-12T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c481aeternaspectrum_cancer_drug_begins_phase_ii_/</loc>
		<lastmod>2005-04-12T11:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c44bamerck_files_for_rotavirus_va/</loc>
		<lastmod>2005-04-12T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a04a1neuro3d_antipsychotic_proves_effective_in_phase_ii/</loc>
		<lastmod>2005-04-13T10:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f34aflorusroche_drug_combo_shows_promise_in_kidney_cance/</loc>
		<lastmod>2005-04-13T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba49esirna_collaborator_announces_huntingtons_breakthrough/</loc>
		<lastmod>2005-04-13T10:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4b8provectus_prepares_filing_for_skin_drug_trial/</loc>
		<lastmod>2005-04-13T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4baosel_initiates_two_phase_ii_lactinv_t/</loc>
		<lastmod>2005-04-13T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d482imclone_falls_on_cancer_drug_/</loc>
		<lastmod>2005-04-13T11:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984afelan_up_on_positive_tsyabri/</loc>
		<lastmod>2005-04-13T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c4b4onsource_to_merge_with_osm/</loc>
		<lastmod>2005-04-13T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2648dlife_therapeutics_boosted_by_vaccine_complications/</loc>
		<lastmod>2005-04-13T11:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3448dstudy_shows_eisai_antiepileptic_safer_for_oral_contraceptive_/</loc>
		<lastmod>2005-04-13T11:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/294abalnylam_and_benitec_up_on_rnai/</loc>
		<lastmod>2005-04-13T11:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba49aperlegen_licenses_diabetes_compound_from_mitsubishi_p/</loc>
		<lastmod>2005-04-14T02:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7648bevotec_and_roche_expand_chemistry/</loc>
		<lastmod>2005-04-14T07:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7549bdr_reddys_to_launch_celadrin_in_/</loc>
		<lastmod>2005-04-14T09:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7348fkos_and_barr_settle_cholesterol_drug_litig/</loc>
		<lastmod>2005-04-14T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3f4b5sosei_compounds_to_be_tested_for_new_indication/</loc>
		<lastmod>2005-04-14T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c74aanovartis_in_drug_development_deal_with_uk_biote/</loc>
		<lastmod>2005-04-14T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54b6gsks_lamictal_effective_as_addon_therap/</loc>
		<lastmod>2005-04-14T10:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f491vion_anticancer_agent_enters_child_trial/</loc>
		<lastmod>2005-04-14T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/084a3questcor_announces_new_neurology_focus_/</loc>
		<lastmod>2005-04-14T10:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5149escheringplough_to_develop_fifth_pharmacopeia_compoun/</loc>
		<lastmod>2005-04-14T10:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a48bseattle_genetics_inlicenses_pdl_antibody_program/</loc>
		<lastmod>2005-04-14T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47491lilly_to_develop_xencor_protein/</loc>
		<lastmod>2005-04-14T10:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4248eym_biosciences_to_buy_delex_ther/</loc>
		<lastmod>2005-04-14T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca495japanese_research_suggests_diabetes_gene_therapy_potentia/</loc>
		<lastmod>2005-04-14T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/98498ibuprofen_may_lower_parkinsons_risk_study_show/</loc>
		<lastmod>2005-04-14T11:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea485aeternaspectrum_compound_begins_phase_ii_prostate_tria/</loc>
		<lastmod>2005-04-14T11:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/514b7alltracels_mdoc_reduces_choles/</loc>
		<lastmod>2005-04-15T06:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4b0cenes_and_tripos_extend_parkinsons_partne/</loc>
		<lastmod>2005-04-15T06:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc4aclilly_triumphs_in_zyprexa_patent/</loc>
		<lastmod>2005-04-15T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/21486abbott_selects_celera_cancer_treatment_ta/</loc>
		<lastmod>2005-04-15T08:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/914bdspectrum_and_cura_form_carboplatin_marketing_all/</loc>
		<lastmod>2005-04-15T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c489bionaut_and_analyticon_to_develop_novel_anticancer_comp/</loc>
		<lastmod>2005-04-15T10:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c64a9idenix_encouraged_by_continued_hepatitis_re/</loc>
		<lastmod>2005-04-15T10:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/054a1genentech_extends_curis_cancer_fundin/</loc>
		<lastmod>2005-04-15T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7149cmercks_hyzaar_approved_for_new_stroke_indicatio/</loc>
		<lastmod>2005-04-15T10:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4beentremeds_panzem_granted_fda_orphan_statu/</loc>
		<lastmod>2005-04-15T10:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/37493human_genome_sciences_albuferon_effective_in_hepatitis_trial/</loc>
		<lastmod>2005-04-15T10:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/af4bbchiron_and_berlex_ms_drug_shows_longterm_s/</loc>
		<lastmod>2005-04-15T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e1496genentech_soars_on_avastin_study_su/</loc>
		<lastmod>2005-04-18T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa4bbadventrx_colorectal_cancer_trial_gets_uk_app/</loc>
		<lastmod>2005-04-18T07:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a8494genvec_hiv_vaccine_welltolerated_in_ph/</loc>
		<lastmod>2005-04-18T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/49492prestwick_drug_effective_in_child_movement_diso/</loc>
		<lastmod>2005-04-18T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d1492peregrine_compound_enhances_multiple_chemo_/</loc>
		<lastmod>2005-04-18T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/854bdroche_drops_memory_comp/</loc>
		<lastmod>2005-04-18T08:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a4abcollagenex_compound_eases_rosacea_in_phase_i/</loc>
		<lastmod>2005-04-18T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4afinyx_gets_exclusive_kos_inhaler_contrac/</loc>
		<lastmod>2005-04-18T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d49apoint_thera_reports_further_preclinical_success_with_talabosta/</loc>
		<lastmod>2005-04-18T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/72492curagen_compound_shows_potent_activity_in_melanom/</loc>
		<lastmod>2005-04-18T10:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/864b6scottish_health_minister_to_launch_major_clinical_trials_projec/</loc>
		<lastmod>2005-04-18T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4b3chocolate_compound_stops_cancer_cell_cycle_study_sho/</loc>
		<lastmod>2005-04-18T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c94bdmorphosys_and_jpt_sign_antibodies_deal/</loc>
		<lastmod>2005-04-19T09:49:00+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->